
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Evaluating the Combined Effect of a Choline Kinase Inhibitor and Temozolomide Therapy in a Mouse Model of Glioblastoma Using 1H MR Spectroscopy and IVIM‐DWI - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="67D710F389B705B31C10F30019A03654.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12319478/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Nmr in Biomedicine">
<meta name="citation_title" content="Evaluating the Combined Effect of a Choline Kinase Inhibitor and Temozolomide Therapy in a Mouse Model of Glioblastoma Using 1H MR Spectroscopy and IVIM‐DWI">
<meta name="citation_author" content="Tareq Alrashidi">
<meta name="citation_author_institution" content="Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK">
<meta name="citation_author" content="Sourav Bhaduri">
<meta name="citation_author_institution" content="Institute for Advancing Intelligence (IAI), TCG CREST, Kolkata, India">
<meta name="citation_author_institution" content="Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India">
<meta name="citation_author" content="Elisabeth Non Gash">
<meta name="citation_author_institution" content="Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK">
<meta name="citation_author" content="Mohesh Moothanchery">
<meta name="citation_author_institution" content="Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK">
<meta name="citation_author" content="Christopher Ball">
<meta name="citation_author_institution" content="Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK">
<meta name="citation_author" content="Mahon L Maguire">
<meta name="citation_author_institution" content="Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK">
<meta name="citation_author" content="Lorenzo Ressel">
<meta name="citation_author_institution" content="Department of Veterinary Anatomy Physiology and Pathology, University of Liverpool, Chester, UK">
<meta name="citation_author" content="Harish Poptani">
<meta name="citation_author_institution" content="Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK">
<meta name="citation_publication_date" content="2025 Aug 4">
<meta name="citation_volume" content="38">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="e70113">
<meta name="citation_doi" content="10.1002/nbm.70113">
<meta name="citation_pmid" content="40755153">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12319478/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12319478/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12319478/pdf/NBM-38-e70113.pdf">
<meta name="description" content="This study evaluated the therapeutic efficacy of combining a choline kinase alpha (ChoKα) inhibitor, MN58b, and temozolomide (TMZ) in a syngeneic GL261 glioblastoma (GBM) mouse model. It used MR spectroscopy (MRS) and intravoxel incoherent motion ...">
<meta name="og:title" content="Evaluating the Combined Effect of a Choline Kinase Inhibitor and Temozolomide Therapy in a Mouse Model of Glioblastoma Using 1H MR Spectroscopy and IVIM‐DWI">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="This study evaluated the therapeutic efficacy of combining a choline kinase alpha (ChoKα) inhibitor, MN58b, and temozolomide (TMZ) in a syngeneic GL261 glioblastoma (GBM) mouse model. It used MR spectroscopy (MRS) and intravoxel incoherent motion ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12319478/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12319478">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1002/nbm.70113"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/NBM-38-e70113.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12319478%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12319478/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12319478/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12319478/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1002/nbm.70113" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">NMR Biomed</button></div>. 2025 Aug 4;38(9):e70113. doi: <a href="https://doi.org/10.1002/nbm.70113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1002/nbm.70113</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22NMR%20Biomed%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22NMR%20Biomed%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22NMR%20Biomed%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22NMR%20Biomed%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Evaluating the Combined Effect of a Choline Kinase Inhibitor and Temozolomide Therapy in a Mouse Model of Glioblastoma Using <sup>1</sup>H MR Spectroscopy and IVIM‐DWI</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alrashidi%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Tareq Alrashidi</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Tareq Alrashidi</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alrashidi%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Tareq Alrashidi</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bhaduri%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Sourav Bhaduri</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Sourav Bhaduri</span></h3>
<div class="p">
<sup>
<sup>2</sup>
</sup>Institute for Advancing Intelligence (IAI), TCG CREST, Kolkata, India</div>
<div class="p">
<sup>
<sup>3</sup>
</sup>Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bhaduri%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Sourav Bhaduri</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gash%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Elisabeth Non Gash</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Elisabeth Non Gash</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gash%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Elisabeth Non Gash</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moothanchery%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Mohesh Moothanchery</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Mohesh Moothanchery</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Moothanchery%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohesh Moothanchery</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ball%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Christopher Ball</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Christopher Ball</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ball%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christopher Ball</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maguire%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Mahon L Maguire</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Mahon L Maguire</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Maguire%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mahon L Maguire</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ressel%20L%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Lorenzo Ressel</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Lorenzo Ressel</span></h3>
<div class="p">
<sup>
<sup>4</sup>
</sup>Department of Veterinary Anatomy Physiology and Pathology, University of Liverpool, Chester, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ressel%20L%22%5BAuthor%5D" class="usa-link"><span class="name western">Lorenzo Ressel</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Poptani%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Harish Poptani</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Harish Poptani</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Poptani%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Harish Poptani</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="nbm70113-aff-0001">
<sup>
<sup>1</sup>
</sup>Centre for PreClinical Imaging, University of Liverpool, Liverpool, UK</div>
<div id="nbm70113-aff-0002">
<sup>
<sup>2</sup>
</sup>Institute for Advancing Intelligence (IAI), TCG CREST, Kolkata, India</div>
<div id="nbm70113-aff-0003">
<sup>
<sup>3</sup>
</sup>Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, India</div>
<div id="nbm70113-aff-0004">
<sup>
<sup>4</sup>
</sup>Department of Veterinary Anatomy Physiology and Pathology, University of Liverpool, Chester, UK</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Harish Poptani (<span>harish.poptani@liverpool.ac.uk</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jul 21; Received 2025 Mar 1; Accepted 2025 Jul 24; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>NMR in Biomedicine</em> published by John Wiley &amp; Sons Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12319478  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40755153/" class="usa-link">40755153</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>This study evaluated the therapeutic efficacy of combining a choline kinase alpha (ChoK<em>α</em>) inhibitor, MN58b, and temozolomide (TMZ) in a syngeneic GL261 glioblastoma (GBM) mouse model. It used MR spectroscopy (MRS) and intravoxel incoherent motion diffusion‐weighted imaging (IVIM‐DWI) to assess metabolic and microstructural changes within the tumor. Fifty‐two C57BL/6 mice had GL261 cells implanted intracranially and were divided into four groups: saline control, MN58b, TMZ, and MN58b + TMZ (<em>n</em> = 16, 14, 11, and 11, respectively). Treatments were administered for 5 days, starting 10 days post‐implantation. MRI scans (T<sub>2</sub>‐weighted, MRS, IVIM‐DWI) were performed at baseline, during treatment (Day 3), and post‐treatment (Day 6). The histological analysis evaluated the tumor mitotic index and caspase‐3 expression. Combination therapy with MN58b + TMZ significantly reduced tCho/NAA, Lip + Lac/tCr, and mI/tCr, suggesting decreased phosphocholine synthesis and tumor proliferation. IVIM‐DWI showed a significant increase in diffusion coefficient (D) values, indicating reduced cell density. Metabolic changes detected by <sup>1</sup>H MRS were observable as early as Day 3 post‐treatment initiation, preceding microstructural alterations detected by IVIM‐DWI at Day 6. This suggests that MRS biomarkers may serve as early indicators of treatment response, facilitating timely therapeutic decisions. Histology confirmed a significantly lower mitotic index relative to control tumors in the combination treatment group. Significantly prolonged survival with combination therapy was noted relative to other groups. However, the tumor volumes were not significantly different between groups. Combination therapy targeting ChoK<em>α</em> and cellular proliferation with MN58b and TMZ outperformed individual treatments for GBM, warranting further exploration. The integration of MN58b with the current standard of care (TMZ + RT) might further enhance the therapeutic outcomes. MRS and IVIM‐DWI demonstrate potential utility as non‐invasive imaging markers for treatment monitoring.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> cancer, GBM, glioblastoma, IVIM, microstructure, MR spectroscopy, treatment response</p></section></section><section class="abstract" id="abstract2"><hr class="headless">
<p>Significant decreases in tCho/NAA along with increased apparent diffusion coefficient were observed in response to a combinatorial effect of temozolomide and choline kinase inhibitor in a mouse model of glioblastoma. These changes corresponded to reduced mitoses and occurred prior to changes in tumour volume, indicating imaging and spectroscopy could be used as early markers of treatment response.</p>
<section class="bt xbox font-sm" id="nbm70113-blkfxd-0001"><p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e12/12319478/860a13aaf5d9/NBM-38-e70113-g002.jpg" loading="lazy" id="jats-graphic-1" height="285" width="472" alt="graphic file with name NBM-38-e70113-g002.jpg"></p></section></section><hr class="headless">
<h3>Abbreviations</h3>
<dl class="def-list" id="nbm70113-dl-0001">
<dt id="nbm70113-li-0001">ADC</dt>
<dd id="nbm70113-li-0002"><p>apparent diffusion coefficient</p></dd>
<dt id="nbm70113-li-0003">ANOVA</dt>
<dd id="nbm70113-li-0004"><p>analysis of variance</p></dd>
<dt id="nbm70113-li-0005">BBB</dt>
<dd id="nbm70113-li-0006"><p>blood–brain barrier</p></dd>
<dt id="nbm70113-li-0007">ChoKα</dt>
<dd id="nbm70113-li-0009"><p>choline kinase alpha</p></dd>
<dt id="nbm70113-li-0010">CKIs</dt>
<dd id="nbm70113-li-0011"><p>choline kinase inhibitors</p></dd>
<dt id="nbm70113-li-0012">CRLB</dt>
<dd id="nbm70113-li-0013"><p>Cramér–Rao lower bound</p></dd>
<dt id="nbm70113-li-0014">CT</dt>
<dd id="nbm70113-li-0015"><p>computed tomography</p></dd>
<dt id="nbm70113-li-0016">DAB</dt>
<dd id="nbm70113-li-0017"><p>diaminobenzidine</p></dd>
<dt id="nbm70113-li-0018">DW‐MRI</dt>
<dd id="nbm70113-li-0019"><p>diffusion‐weighted MRI</p></dd>
<dt id="nbm70113-li-0020">EGFR</dt>
<dd id="nbm70113-li-0021"><p>epidermal growth factor receptor</p></dd>
<dt id="nbm70113-li-0022">FOV</dt>
<dd id="nbm70113-li-0023"><p>field of view</p></dd>
<dt id="nbm70113-li-0024">GBM</dt>
<dd id="nbm70113-li-0025"><p>glioblastoma</p></dd>
<dt id="nbm70113-li-0026">GLUT3</dt>
<dd id="nbm70113-li-0027"><p>glucose transporter 3</p></dd>
<dt id="nbm70113-li-0028">Glx</dt>
<dd id="nbm70113-li-0029"><p>glutamate–glutamine</p></dd>
<dt id="nbm70113-li-0030">GSCs</dt>
<dd id="nbm70113-li-0031"><p>glioma stem cells</p></dd>
<dt id="nbm70113-li-0032">HLSVD</dt>
<dd id="nbm70113-li-0033"><p>Hankel Lanczos singular value decomposition</p></dd>
<dt id="nbm70113-li-0034">IHC</dt>
<dd id="nbm70113-li-0035"><p>immunohistochemistry</p></dd>
<dt id="nbm70113-li-0036">IVIM</dt>
<dd id="nbm70113-li-0037"><p>intravoxel incoherent motion</p></dd>
<dt id="nbm70113-li-0038">Lip + Lac</dt>
<dd id="nbm70113-li-0039"><p>lipid pluslactate</p></dd>
<dt id="nbm70113-li-0040">MGMT</dt>
<dd id="nbm70113-li-0041"><p>methyl guanine‐DNA methyl transferase</p></dd>
<dt id="nbm70113-li-0042">mI</dt>
<dd id="nbm70113-li-0043"><p>myo‐inositol</p></dd>
<dt id="nbm70113-li-0044">MRI</dt>
<dd id="nbm70113-li-0045"><p>magnetic resonance imaging</p></dd>
<dt id="nbm70113-li-0046">MRS</dt>
<dd id="nbm70113-li-0047"><p>magnetic resonance spectroscopy</p></dd>
<dt id="nbm70113-li-0048">NAA</dt>
<dd id="nbm70113-li-0049"><p>N‐acetylaspartate</p></dd>
<dt id="nbm70113-li-0050">NF1</dt>
<dd id="nbm70113-li-0051"><p>Neurofibromin 1</p></dd>
<dt id="nbm70113-li-0052">NIVO</dt>
<dd id="nbm70113-li-0053"><p>nivolumab</p></dd>
<dt id="nbm70113-li-0054">OS</dt>
<dd id="nbm70113-li-0055"><p>overall survival</p></dd>
<dt id="nbm70113-li-0056">PC</dt>
<dd id="nbm70113-li-0057"><p>phosphocholine</p></dd>
<dt id="nbm70113-li-0058">PDGFRA</dt>
<dd id="nbm70113-li-0059"><p>platelet‐derived growth factor receptor A</p></dd>
<dt id="nbm70113-li-0060">PRESS</dt>
<dd id="nbm70113-li-0061"><p>point‐resolved spectroscopy</p></dd>
<dt id="nbm70113-li-0062">PUFA</dt>
<dd id="nbm70113-li-0063"><p>polyunsaturated fatty acid</p></dd>
<dt id="nbm70113-li-0064">QUEST</dt>
<dd id="nbm70113-li-0065"><p>quantum estimation</p></dd>
<dt id="nbm70113-li-0066">RANO</dt>
<dd id="nbm70113-li-0067"><p>response assessment in neuro‐oncology</p></dd>
<dt id="nbm70113-li-0068">RARE</dt>
<dd id="nbm70113-li-0069"><p>rapid acquisition with relaxation enhancement</p></dd>
<dt id="nbm70113-li-0070">ROI</dt>
<dd id="nbm70113-li-0071"><p>region of interest</p></dd>
<dt id="nbm70113-li-0072">RT</dt>
<dd id="nbm70113-li-0073"><p>radiation therapy</p></dd>
<dt id="nbm70113-li-0074">TCA</dt>
<dd id="nbm70113-li-0075"><p>tricarboxylic acid</p></dd>
<dt id="nbm70113-li-0076">tCho</dt>
<dd id="nbm70113-li-0077"><p>total choline</p></dd>
<dt id="nbm70113-li-0078">tCr</dt>
<dd id="nbm70113-li-0079"><p>total creatine</p></dd>
<dt id="nbm70113-li-0080">TE</dt>
<dd id="nbm70113-li-0081"><p>time of echo</p></dd>
<dt id="nbm70113-li-0082">TME</dt>
<dd id="nbm70113-li-0083"><p>tumor microenvironment</p></dd>
<dt id="nbm70113-li-0084">TMZ</dt>
<dd id="nbm70113-li-0085"><p>temozolomide</p></dd>
<dt id="nbm70113-li-0086">TR</dt>
<dd id="nbm70113-li-0087"><p>time of repetition</p></dd>
<dt id="nbm70113-li-0088">VEGF</dt>
<dd id="nbm70113-li-0089"><p>vascular endothelial growth factor</p></dd>
</dl>
<section id="nbm70113-sec-0001"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Glioblastomas (GBMs) are highly aggressive brain tumors associated with poor prognoses [<a href="#nbm70113-bib-0001" class="usa-link" aria-describedby="nbm70113-bib-0001">1</a>]. Patients with GBM have a median survival time of less than 15 months following diagnosis [<a href="#nbm70113-bib-0002" class="usa-link" aria-describedby="nbm70113-bib-0002">2</a>]. Typically, a mass‐occupying lesion in the brain demonstrating contrast enhancement on computed tomography (CT) or magnetic resonance imaging (MRI) is observed in a majority of patients with GBM [<a href="#nbm70113-bib-0003" class="usa-link" aria-describedby="nbm70113-bib-0003">3</a>, <a href="#nbm70113-bib-0004" class="usa-link" aria-describedby="nbm70113-bib-0004">4</a>]. The current standard of care for GBM entails maximal safe resection of the tumor followed by concurrent and adjuvant temozolomide (TMZ) along with radiation therapy (RT). This regimen has significantly improved 2‐year overall survival (OS) from 10.9% with RT alone to 27.2% with TMZ + RT [<a href="#nbm70113-bib-0005" class="usa-link" aria-describedby="nbm70113-bib-0005">5</a>, <a href="#nbm70113-bib-0006" class="usa-link" aria-describedby="nbm70113-bib-0006">6</a>].</p>
<p>TMZ, a second‐generation alkylating agent, efficiently crosses the blood–brain barrier (BBB) and exhibits excellent oral bioavailability. It's anticancer activity is mediated by DNA methylation. Methylation of the O6‐methylguanine‐DNA methyltransferase (MGMT) promoter reduces MGMT expression, increasing chemosensitivity and decreasing DNA repair capability. Despite this, MGMT‐methylated tumors eventually develop resistance to TMZ with inevitable tumor recurrence, contributing to poor prognosis [<a href="#nbm70113-bib-0007" class="usa-link" aria-describedby="nbm70113-bib-0007">7</a>, <a href="#nbm70113-bib-0008" class="usa-link" aria-describedby="nbm70113-bib-0008">8</a>]. As such, novel drugs are desperately needed to overcome treatment resistance. However, drugs targeting angiogenesis, such as bevacizumab, have not improved OS outcomes in patients with GBMs [<a href="#nbm70113-bib-0009" class="usa-link" aria-describedby="nbm70113-bib-0009">9</a>].</p>
<p>A hallmark of cancer is altered cellular metabolism, with increased aerobic glycolysis being one of the most frequently identified aberrant metabolic changes [<a href="#nbm70113-bib-0010" class="usa-link" aria-describedby="nbm70113-bib-0010">10</a>, <a href="#nbm70113-bib-0011" class="usa-link" aria-describedby="nbm70113-bib-0011">11</a>]. In heterogeneous cancers like GBM, metabolic plasticity has also been observed [<a href="#nbm70113-bib-0012" class="usa-link" aria-describedby="nbm70113-bib-0012">12</a>, <a href="#nbm70113-bib-0013" class="usa-link" aria-describedby="nbm70113-bib-0013">13</a>]. A previous study reported that <sup>13</sup>C‐glucose infusion during operative resection of a cerebral tumor resulted in pyruvate dehydrogenase‐driven oxidation of <sup>13</sup>C‐pyruvate into the tricarboxylic acid (TCA) cycle [<a href="#nbm70113-bib-0012" class="usa-link" aria-describedby="nbm70113-bib-0012">12</a>]. This highlights the fluctuating metabolic nature within the tumor microenvironment (TME) depending on glucose availability. Because reprogramming metabolic activity contributes to oncogenesis, targeting metabolic processes may represent a promising strategy for new cancer therapeutics [<a href="#nbm70113-bib-0014" class="usa-link" aria-describedby="nbm70113-bib-0014">14</a>].</p>
<p>Recent research indicates that glioma stem cell's (GSCs) high glucose demand promotes their survival by upregulating glucose transporter 3 (GLUT3) [<a href="#nbm70113-bib-0015" class="usa-link" aria-describedby="nbm70113-bib-0015">15</a>]. Increased glycolysis and overexpression of GLUT3 and hexokinase II are linked to poor prognosis in GBM [<a href="#nbm70113-bib-0015" class="usa-link" aria-describedby="nbm70113-bib-0015">15</a>, <a href="#nbm70113-bib-0016" class="usa-link" aria-describedby="nbm70113-bib-0016">16</a>]. Furthermore, molecular subtypes of GBM exhibit changes in genes that include epidermal growth factor receptor (EGFR), Neurofibromin 1 (NF1), and platelet‐derived growth factor receptor A (PDGFRA), which affect various metabolic pathways.</p>
<p>In gliomas, EGFR overexpression drives the upregulation of choline transporters and enhances choline kinase α (ChoKα) activity, leading to increased choline uptake and metabolism. This EGFR‐mediated metabolic reprogramming results in elevated phosphocholine (PC) and total choline (tCho) [<a href="#nbm70113-bib-0017" class="usa-link" aria-describedby="nbm70113-bib-0017">17</a>, <a href="#nbm70113-bib-0018" class="usa-link" aria-describedby="nbm70113-bib-0018">18</a>]. Hence, targeting metabolic pathways could also offer a way to overcome therapy resistance [<a href="#nbm70113-bib-0005" class="usa-link" aria-describedby="nbm70113-bib-0005">5</a>, <a href="#nbm70113-bib-0019" class="usa-link" aria-describedby="nbm70113-bib-0019">19</a>].</p>
<p>Abnormal choline metabolism has been recognized as a sign of malignancy [<a href="#nbm70113-bib-0020" class="usa-link" aria-describedby="nbm70113-bib-0020">20</a>]. Upregulation of choline kinase alpha (ChoK<em>α</em>) has transformed normal tissue into a neoplastic phenotype [<a href="#nbm70113-bib-0017" class="usa-link" aria-describedby="nbm70113-bib-0017">17</a>]. The discovery of upregulated ChoK activity has driven the development of new anticancer therapies to inhibit this enzyme. Several choline kinase inhibitors (CKIs) have shown antiproliferative effects [<a href="#nbm70113-bib-0021" class="usa-link" aria-describedby="nbm70113-bib-0021">21</a>, <a href="#nbm70113-bib-0022" class="usa-link" aria-describedby="nbm70113-bib-0022">22</a>]. MN58b, a first‐generation CKI, has demonstrated efficacy in vitro and in vivo [<a href="#nbm70113-bib-0023" class="usa-link" aria-describedby="nbm70113-bib-0023">23</a>]. However, a recent study by Bhaduri et al. did not show any significant therapeutic benefit despite metabolic alterations in tCho levels in the GL261 model treated with the CKI, JAS239 [<a href="#nbm70113-bib-0024" class="usa-link" aria-describedby="nbm70113-bib-0024">24</a>]. These findings suggest that while CKIs may effectively modulate tumor metabolism, their ability to reduce tumor growth or improve survival outcomes may be limited in aggressive GBM.</p>
<p>TMZ is the standard chemotherapy for GBM; however, resistance mechanisms often limit its efficacy, including the DNA repair enzyme O6‐methylguanine‐DNA methyltransferase (MGMT) and other DNA repair pathways. MN58b is a ChoKα inhibitor that disrupts choline metabolism, an upregulated pathway in GBM. Our rationale is that combining TMZ with MN58b will target both DNA integrity and membrane phospholipid metabolism, potentially overcoming resistance and addressing the need for more effective treatments for GBM. This might be a more effective approach as targeting angiogenesis, such as with bevacizumab, has not improved OS outcomes in patients with GBMs.</p>
<p>MRI is widely used to monitor tumor response to therapy in clinical and preclinical settings. However, traditional MRI methods cannot always distinguish treatment response from progression, as both may present similar imaging features [<a href="#nbm70113-bib-0025" class="usa-link" aria-describedby="nbm70113-bib-0025">25</a>, <a href="#nbm70113-bib-0026" class="usa-link" aria-describedby="nbm70113-bib-0026">26</a>]. Changes in tumor microstructure and metabolism may precede volumetric changes and are not always detected with conventional MRI [<a href="#nbm70113-bib-0027" class="usa-link" aria-describedby="nbm70113-bib-0027">27</a>, <a href="#nbm70113-bib-0028" class="usa-link" aria-describedby="nbm70113-bib-0028">28</a>]. We assessed the efficacy of this combination therapy in a syngeneic GBM mouse model employing magnetic resonance spectroscopy (MRS) for evaluating metabolic alterations and diffusion‐weighted MRI (DW‐MRI), specifically intravoxel incoherent motion (IVIM) imaging to monitor microstructural changes within the tumor.</p></section><section id="nbm70113-sec-0002"><h2 class="pmc_sec_title">2. Materials and Methods</h2>
<p>University of Liverpool's Animal Welfare and Ethical Review Board authorized all animal experiments that followed ARRIVE principles, and the study was approved by the Home Office in compliance with the UK Animals (Scientific Procedures) Act 1986, as revised in 2012.</p>
<p>Two hundred fifty thousand GL261 cells (ATCC, USA) were transplanted intracranially into male C57BL/6 mice (age: 8–12 weeks, weight: 20–23 g, <em>N</em> = 52). A rectal probe and a respiratory pillow were used to measure the animal's body temperature and breathing rate after having been anesthetized with 2% isoflurane in O<sub>2</sub>. The animal was secured employing a stereotaxic frame, and a burr hole was drilled 2.0 mm posteriorly from bregma and 1.5 mm to the right. GBM cells suspended in 5 <em>μ</em>L of serum‐free media were injected into the right brain cortex at a depth of 2 mm from the surface.</p>
<section id="nbm70113-sec-0003"><h3 class="pmc_sec_title">2.1. Drug Treatment of Mice Bearing GL261 GBM</h3>
<p>All mice successfully developed tumors and were randomly divided into four groups: saline control (<em>n</em> = 16), MN58b (<em>n</em> = 14), TMZ (<em>n</em> = 11), and a combination therapy group (MN58b + TMZ, <em>n</em> = 11). All animals received a single dose every day for five consecutive days. Treatment commenced when tumors exceeded 2 mm in diameter, typically 10 days post‐implantation. The control group received intraperitoneal injections of saline, the MN58b group received 4 mg/kg of MN58b intraperitoneally [<a href="#nbm70113-bib-0029" class="usa-link" aria-describedby="nbm70113-bib-0029">29</a>], the TMZ group received 50 mg/kg TMZ orally via gavage [<a href="#nbm70113-bib-0030" class="usa-link" aria-describedby="nbm70113-bib-0030">30</a>], and the combination (MN58b + TMZ) therapy group received both treatments as above.</p></section><section id="nbm70113-sec-0004"><h3 class="pmc_sec_title">2.2. MR Scanning</h3>
<p>A 9.4T Bruker 94/20USR scanner with 440 mT/m imaging gradients was used for all imaging studies (Bruker BioSpin, Germany). An 86 mm birdcage coil was used to transmit the signal, and a 4‐channel phased array surface coil (Bruker BioSpin, Germany) was used to receive the signal. Animals were anaesthetized as described above, and body temperature was maintained using a heated water blanket; respiration and body temperature were monitored throughout scanning. To monitor tumor growth, T<sub>2</sub>‐weighted (RARE) images were acquired (TR/TE/echo spacing [ESP] = 3497/33/11 ms, 2 averages, 33 slices, 0.3 mm slice thickness, FOV = 25 × 25 mm<sup>2</sup>, 256 × 256 matrix, RARE factor = 8, BW = 42 kHz). Animals began receiving treatment once tumors were &gt; 2 mm in diameter, typically 10 days post‐implantation. Animals were scanned at baseline (Day 0), during therapy (Day 3), and at the end of treatment (Day 6). T<sub>2</sub>‐weighted images, single voxel water suppressed and unsuppressed PRESS spectra, and IVIM‐DWI images were acquired at each time point. A 2 × 2 × 2 mm<sup>3</sup> PRESS voxel was placed within the tumor, field map‐based shimming was performed (Mapshim, Bruker; linewidth &lt; 20 Hz), and a <sup>1</sup>H spectrum was acquired (TR/TE = 2000/16.5 ms, 200 averages, 2048 points, spectral width = 4401 Hz, VAPOR water suppression, acquisition time = 6 min 40 s). IVIM DW‐MRI was acquired covering the tumor volume employing a segmented echo‐planar imaging (EPI) readout based spin echo sequence with 5 B<sub>0</sub> images and 13 b‐values (20, 30, 40, 50, 60, 80, 140, 230, 350, 570, 840, 1120, 1460 s/mm<sup>2</sup>) in 3 orthogonal directions (TR/TE = 1800/24.67 ms, 6 segments, FOV = 20 × 20 mm<sup>2</sup>, 96 × 96 matrix, 1.0 mm slice thickness, 1 mm slice gap, 8 slices, 2 averages, diffusion gradient duration/separation = 4.5/10.6 ms, acquisition time = 15 min 50 s). All images were acquired in the axial plane.</p></section></section><section id="nbm70113-sec-0005"><h2 class="pmc_sec_title">3. Data Analysis</h2>
<p>Tumor volumes were measured from the T<sub>2</sub>‐weighted images utilizing ITK‐Snap (Version 4.2.0) (www.itksnap.org). Contouring of the tumor was performed manually by drawing the tumor boundaries on each slice. The areas of the contoured regions on each slice were added, and the result was multiplied by the thickness of each slice for calculating the overall tumor volume.</p>
<p>All spectral processing was carried out using jMRUI 5.2 (www.jmrui.eu) [<a href="#nbm70113-bib-0031" class="usa-link" aria-describedby="nbm70113-bib-0031">31</a>]. The residual water peak at 4.7 ppm was removed employing a Hankel Lanczos singular value decomposition (HLSVD) filter with model order 25 prior to measuring water‐suppressed spectroscopic data [<a href="#nbm70113-bib-0032" class="usa-link" aria-describedby="nbm70113-bib-0032">32</a>, <a href="#nbm70113-bib-0033" class="usa-link" aria-describedby="nbm70113-bib-0033">33</a>]. A 5 Hz Lorentzian line‐broadening function and zero filling to 4196 points were employed for apodization. The QUEST method was applied in jMRUI for fitting metabolite peaks [<a href="#nbm70113-bib-0034" class="usa-link" aria-describedby="nbm70113-bib-0034">34</a>, <a href="#nbm70113-bib-0035" class="usa-link" aria-describedby="nbm70113-bib-0035">35</a>]. A basis set of the metabolites including “total choline (tCho) 3.2 ppm, N‐acetyl‐aspartate (NAA) at 2.01 ppm, glutamate‐glutamine (Glx) 2.35 and 3.74ppm, lipid/lactate (Lip+Lac) 1.3 ppm, total creatine (tCr) 3.03ppm, myo‐inositol+Glycine (mI+Gly) 3.56ppm and other metabolites including glucose, phosphocreatine (at 3.9ppm), lipid (at 0.9ppm), alanine, glutathione, aspartate, glycerophosphocholine, GABA, acetate, phosphorylcholine, N‐acetylaspartylglutamate, scyllo‐inositol and taurine” were simulated employing NMR scope tool within jMRUI [<a href="#nbm70113-bib-0030" class="usa-link" aria-describedby="nbm70113-bib-0030">30</a>]. The peaks at 1.3 and 0.9 ppm correspond to macromolecules, including lipids. Water amplitude was determined by fitting the water resonance obtained from unsuppressed water spectra. The following equation was used for scaling spectra to unsuppressed water signals, considering the correction factors for T<sub>1</sub> and T<sub>2</sub> of water [<a href="#nbm70113-bib-0036" class="usa-link" aria-describedby="nbm70113-bib-0036">36</a>].</p>
<table class="disp-formula p" id="nbm70113-disp-0001"><tr>
<td class="formula"><math id="jats-math-1" display="block" overflow="linebreak"><mrow><mrow><mtext mathvariant="italic">Correction factor</mtext><mo linebreak="goodbreak">=</mo><mn>1</mn><mo linebreak="goodbreak">−</mo><msup><mi>e</mi><mfrac><mrow><mo>−</mo><mi mathvariant="italic">TR</mi></mrow><msub><mi>T</mi><mrow><mn>1</mn><mo>,</mo><mtext mathvariant="italic">water</mtext></mrow></msub></mfrac></msup><msup><mi>e</mi><mfrac><mrow><mo>−</mo><mi mathvariant="italic">TE</mi></mrow><msub><mi>T</mi><mrow><mn>2</mn><mo>,</mo><mtext mathvariant="italic">water</mtext></mrow></msub></mfrac></msup></mrow></mrow></math></td>
<td class="label">(1)</td>
</tr></table>
<p>Using the T<sub>1<em>,water</em>
</sub> = 2097 <em>±</em> 68 ms and T<sub>2<em>,water</em>
</sub> = 42 <em>±</em> 1.6 ms as reported for rat brain at 9.4T [<a href="#nbm70113-bib-0037" class="usa-link" aria-describedby="nbm70113-bib-0037">37</a>]. Cramér–Rao lower bound (CRLB) criteria were employed to evaluate the quality of the fitting. CRLB/amplitude &lt; 20% was used in discriminating well‐fitted from poorly fitted metabolites. All metabolites within the spectrum that fulfilled this criterion were then employed for data analysis, excluding the ones that did not. A representative example of the MRS fitting performance is shown in Figure <a href="#nbm70113-supitem-0002" class="usa-link">S1</a>, adapted from our previously published work [<a href="#nbm70113-bib-0024" class="usa-link" aria-describedby="nbm70113-bib-0024">24</a>]. Several factors confound absolute metabolite quantification in tumors, like significant heterogeneity in T1 and T2 relaxation times within gliomas due to necrosis, edema, and disrupted vasculature; variability in water content and cellular density; partial volume effects due to infiltrative tumor margins. These confounders introduce substantial uncertainty in water‐scaling–based absolute quantification. Metabolite ratios were therefore measured with respect to tCr, a commonly used internal reference in MRS due to its relatively stable levels in normal and tumor tissues, allowing for consistent comparisons.</p></section><section id="nbm70113-sec-0006"><h2 class="pmc_sec_title">4. Parameter Calculation</h2>
<p>All images were processed with an in‐house pipeline employing MATLAB 2021a (Mathworks, USA). The data were analyzed and fitted on a pixel‐by‐pixel basis using the Levenberg–Marquardt algorithm [<a href="#nbm70113-bib-0038" class="usa-link" aria-describedby="nbm70113-bib-0038">38</a>].</p>
<p>IVIM describes the signal intensity from an image acquired with a b‐value where <em>b</em> = 0 (S<sub>0</sub>) and <em>b</em> &gt; 0 s/mm<sup>2</sup> (S<sub>
<em>b</em>
</sub>):</p>
<table class="disp-formula p" id="nbm70113-disp-0002"><tr>
<td class="formula"><math id="jats-math-2" display="block" overflow="linebreak"><mrow><mrow><mfrac><msub><mi>S</mi><mi>b</mi></msub><msub><mi>S</mi><mn>0</mn></msub></mfrac><mo linebreak="goodbreak">=</mo><msup><mi mathvariant="italic">fe</mi><mrow><mo>−</mo><mi>b</mi><msup><mi>D</mi><mo>*</mo></msup></mrow></msup><mo linebreak="goodbreak">+</mo><mfenced close=")" open="("><mrow><mn>1</mn><mo linebreak="goodbreak">−</mo><mi>f</mi></mrow></mfenced><msup><mi>e</mi><mrow><mo>−</mo><mi mathvariant="italic">bD</mi></mrow></msup></mrow></mrow></math></td>
<td class="label">(2)</td>
</tr></table>
<p>where <em>b</em> is the magnitude of the applied diffusion gradient in s/mm<sup>2</sup>, <em>D*</em> is the pseudo diffusion coefficient in mm<sup>2</sup>/s due to effects of blood flow, <em>D</em> is the diffusion coefficient in mm<sup>2</sup>/s, and <em>f</em> is the fraction of volume occupied by blood flowing in the voxel [<a href="#nbm70113-bib-0039" class="usa-link" aria-describedby="nbm70113-bib-0039">39</a>]. When <em>b</em> &gt; 200 s/mm<sup>2</sup>, the value of <em>fe</em>
<sup>
<em>−bD*</em>
</sup> can be neglected, and the equation can be simplified to [<a href="#nbm70113-bib-0040" class="usa-link" aria-describedby="nbm70113-bib-0040">40</a>]:</p>
<table class="disp-formula p" id="nbm70113-disp-0003"><tr>
<td class="formula"><math id="jats-math-3" display="block" overflow="linebreak"><mrow><mrow><mfrac><msub><mi>S</mi><mi>b</mi></msub><msub><mi>S</mi><mn>0</mn></msub></mfrac><mo linebreak="goodbreak">=</mo><mfenced close=")" open="("><mrow><mn>1</mn><mo linebreak="goodbreak">−</mo><mi>f</mi></mrow></mfenced><msup><mi>e</mi><mrow><mo>−</mo><mi mathvariant="italic">bD</mi></mrow></msup></mrow></mrow></math></td>
<td class="label">(3)</td>
</tr></table>
<p>A linear model can determine <em>D</em> from data at b‐values above &gt; 200 s/mm<sup>2</sup> with zero intercept. As shown below, <em>S</em>
<sub>
<em>int</em>
</sub> determines the perfusion fraction <em>f</em> [<a href="#nbm70113-bib-0041" class="usa-link" aria-describedby="nbm70113-bib-0041">41</a>].</p>
<table class="disp-formula p" id="nbm70113-disp-0004"><tr>
<td class="formula"><math id="jats-math-4" display="block" overflow="linebreak"><mrow><mrow><mi>f</mi><mo linebreak="goodbreak">=</mo><mn>1</mn><mo linebreak="goodbreak">−</mo><mfrac><msub><mi>S</mi><mi mathvariant="italic">int</mi></msub><msub><mi>S</mi><mn>0</mn></msub></mfrac></mrow></mrow></math></td>
<td class="label">(4)</td>
</tr></table>
<p>The data were then fitted to Equation (<a href="#nbm70113-disp-0002" class="usa-link">2</a>) using the value of <em>D</em> obtained from Equation (<a href="#nbm70113-disp-0003" class="usa-link">3</a>) as a fixed value and <em>f</em> calculated from Equation (<a href="#nbm70113-disp-0004" class="usa-link">4</a>) as an initial value. The initial value for <em>D</em>
<sup>
<em>*</em>
</sup> was set to 0.01 mm<sup>2</sup>/s, as described previously [<a href="#nbm70113-bib-0041" class="usa-link" aria-describedby="nbm70113-bib-0041">41</a>]. The values of <em>D</em>
<sup>
<em>*</em>
</sup> and <em>f</em> were then estimated from the nonlinear fit. The full biexponential model in Equation (<a href="#nbm70113-disp-0002" class="usa-link">2</a>) was fit to the entire dataset (<em>b</em> = 0–1460 s/mm<sup>2</sup>). All data were fitted using a nonlinear Levenberg–Marquardt method.</p>
<p>Apparent diffusion coefficient (ADC), which represents a combination of diffusion and perfusion effects, was estimated from the mono‐exponential fit of the diffusion signal decay for all b‐values using:</p>
<table class="disp-formula p" id="nbm70113-disp-0005"><tr>
<td class="formula"><math id="jats-math-5" display="block" overflow="linebreak"><mrow><mrow><mfrac><msub><mi mathvariant="normal">S</mi><mi mathvariant="normal">b</mi></msub><msub><mi mathvariant="normal">S</mi><mn>0</mn></msub></mfrac><mo linebreak="goodbreak">=</mo><msup><mi mathvariant="normal">e</mi><mrow><mo>−</mo><mi mathvariant="normal">b</mi><mo>.</mo><mi>ADC</mi></mrow></msup></mrow></mrow></math></td>
<td class="label">(5)</td>
</tr></table>
<p>In‐house pipeline employing MATLAB 2021a was used to estimate the voxel‐wise metric values of IVIM‐DWI (ADC, <em>D</em>, <em>D*</em>, and <em>f</em>). The IVIM‐DWI and T<sub>2</sub>‐weighted images were used to locate the slices displaying the tumor, and the region of interest (ROI) was contoured manually, covering the whole tumor. All ROIs for IVIM parameter estimation (<em>D</em>, <em>D*</em>, and <em>f</em>) were manually delineated on the b=0 image from the EPI sequence. Separately, ROIs were delineated on the T2‐weighted image to measure the tumor volume.</p></section><section id="nbm70113-sec-0007"><h2 class="pmc_sec_title">5. Histology and Immunohistochemistry (IHC)</h2>
<p>Predefined endpoints, including &gt; 20% body weight loss, reduced mobility, lack of grooming, or tumor volume exceeding 6 mm in diameter, were used as endpoints to sacrifice the animal. Animals were monitored daily and, upon reaching any endpoint, were sacrificed in accordance with approved institutional animal care protocols. Following Day 6 imaging, three animals from each group were sacrificed via an intraperitoneal injection of an overdose of 3 mL/kg pentobarbital sodium (Euthatal, Merial Animal Health Ltd., Harlow, UK). The aorta beneath the diaphragm was severed by making an incision into the abdomen along the mid‐ventral line. A 25‐gauge needle attached to an extension tube was inserted into the heart's left ventricle and secured with a clamp. The heart was initially perfused with 30 mL PBS, then 30 mL 4% formalin (Sigma‐Aldrich, St. Louis, MO). Brains were collected following fixation and then immersed in 4% formalin for fixation. Brains were embedded in paraffin and sectioned into approximately 2‐mm thick transverse sections at the tumor site. Hematoxylin and eosin staining was performed on 4 <em>μ</em>m thick slices containing tumors and adjacent brain tissue. An average number of mitotic cells was computed per high power field (HPF: 400× magnification; ocular FN: 22; objective 40×/0.65 HPF) representing randomly selected HPFs per tumor to calculate the mitotic index, which was evaluated from five regions at the interface of the tumor and the surrounding brain (infiltrating margin).</p>
<p>For IHC, sections were dewaxed and subjected to antigen retrieval in Dako PT buffer high/low pH (Agilent Technologies Ltd., Stockport, UK) using a computer‐controlled antigen retrieval workstation (PT Link; Agilent Technologies Ltd) for 20 min at 98<em>°</em>C. Sections were then stained in an automated immunostainer (Link 48; Agilent Technologies Ltd), using primary antibodies against caspase‐3 (rabbit monoclonal anti‐caspase‐3, 5A1E 1:100). This was followed by a 30 min incubation at room temperature with the secondary antibody and polymer peroxidase‐based detection system (Anti Rabbit Envision Flex+, Agilent Technologies Ltd). The reaction was visualized with diaminobenzidine (DAB—Agilent Technologies Ltd). Consecutive sections incubated with rabbit subclass‐matched unrelated monoclonal antibodies served as negative controls. A distinct brown cytoplasmic stain represented the positive reaction.</p>
<p>For IHC quantification, caspase3‐stained slides were scanned using a Leica Aperio CS2 (Leica Microsystem Limited, Solihull, UK) scanner at 20× magnification. Whole‐slide image analysis was undertaken using QuPath software [<a href="#nbm70113-bib-0042" class="usa-link" aria-describedby="nbm70113-bib-0042">42</a>] as previously described [<a href="#nbm70113-bib-0043" class="usa-link" aria-describedby="nbm70113-bib-0043">43</a>]. Briefly, the tumor area was manually annotated as the ROI excluding the healthy brain. Positive IHC cells were identified by the presence of a brown colour, resulting from the 3,3′diaminobenzidine (DAB) reaction. Positive cell detection parameters were manually optimized based on sample areas from all the cases, and analysis was run for all cases. Two different masks were used to categorize the cells according to staining: negative (blue) and positive (red) (Figure <a href="#nbm70113-supitem-0003" class="usa-link">S2</a>). The software then automatically counted total positive cells and % of positive cells within the ROI.</p></section><section id="nbm70113-sec-0008"><h2 class="pmc_sec_title">6. Statistical Analysis</h2>
<p>Analysis of variance (ANOVA) was performed to evaluate differences among treated groups and the control group (% change in tumor volume, IVIM‐related parameters, and metabolite ratios on Days 3 and 6 scans with respect to baseline [Day 0] values). Bonferroni's post hoc test was utilized for adjusting the <em>p</em>‐value, accounting for the total number of comparisons made. The overall percentage survival was estimated using Kaplan–Meier curves. MATLAB and Prism Version 10.2.0 (GraphPad, USA) were employed for all analyses. A value was considered statistically significant if <em>p</em> &lt; 0.05.</p></section><section id="nbm70113-sec-0009"><h2 class="pmc_sec_title">7. Results</h2>
<section id="nbm70113-sec-0010"><h3 class="pmc_sec_title">7.1. Treatment Effect on GL261 Mouse Glioma Growth</h3>
<p>GL261 GBM tumors were easily discernible, displaying a higher signal intensity than the surrounding brain tissue on T<sub>2</sub>‐weighted images (Figure <a href="#nbm70113-fig-0001" class="usa-link">1A</a>). Tumor volume increased consistently in all cohorts (Figure <a href="#nbm70113-fig-0001" class="usa-link">1C</a>). At baseline, tumor volumes for the different groups were: saline (2.9 <em>±</em> 3.5 mm<sup>3</sup>), MN58b (3.1 <em>±</em> 2.6 mm<sup>3</sup>), TMZ (2.4 <em>±</em> 2.3 mm<sup>3</sup>), and MN58b + TMZ (2.8 <em>±</em> 1.9 mm<sup>3</sup>) (Table <a href="#nbm70113-supitem-0004" class="usa-link">S1</a>). No significant differences were observed in the baseline tumor volumes between groups (<em>p</em> &gt; 0.05). After 6 days of treatment, tumor volume kept increasing in all groups: saline (15.8 <em>±</em> 17.7 mm<sup>3</sup>), MN58b (15.2 <em>±</em> 13.2 mm<sup>3</sup>), TMZ (17.5 <em>±</em> 16.7 mm<sup>3</sup>), and MN58b + TMZ (7.6 <em>±</em> 5.5 mm<sup>3</sup>). While insignificant differences were observed between groups, the MN58b + TMZ treatment group exhibited the lowest increase in percentage change (with respect to baseline) in mean tumor volume compared with the saline control and monotherapy groups, suggesting a trend toward reduced tumor progression (Figure <a href="#nbm70113-fig-0001" class="usa-link">1C</a>).</p>
<figure class="fig xbox font-sm" id="nbm70113-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e12/12319478/6086795aa975/NBM-38-e70113-g003.jpg" loading="lazy" id="jats-graphic-3" height="416" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/nbm70113-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A–D) Treatment effect on GL261 GBM growth. (A) T<sub>2</sub>‐weighted image showing hyperintense tumor relative to the surrounding tissue. (B) Diffusion‐weighted image (<em>b</em> = 0 s/mm<sup>2</sup>) showing the high signal intensity of the tumor compared with the rest of the brain. (C) Percent change in tumor volume relative to Day 0 over treatment time for all cohorts. (D) Kaplan–Meier survival curves showing the survival probability for each group. The asterisk indicates a significant difference between groups at <em>p</em> &lt; 0.05.</p></figcaption></figure></section><section id="nbm70113-sec-0011"><h3 class="pmc_sec_title">7.2. Survival</h3>
<p>Survival probability for each group was estimated using Kaplan–Meier curves. Prolonged survival, in comparison to the saline‐treated group, was observed in the TMZ and combination treatment groups (Figure <a href="#nbm70113-fig-0001" class="usa-link">1D</a>). Specifically, <kbd>~</kbd>85% of mice treated with TMZ alone and 100% of mice treated with the combination of MN58b and TMZ survived until the study endpoint (Day 6), suggesting a combinatorial effect by TMZ and MN58b. Despite the higher survival in the TMZ group, the difference in survival compared with the saline group was not statistically significant (<em>p</em> = 0.1). In contrast, a log‐rank test showed a significant difference between the MN58b + TMZ group and the saline control group (100% vs. 58%, <em>p</em> = 0.02, Figure <a href="#nbm70113-fig-0001" class="usa-link">1D</a>).</p></section><section id="nbm70113-sec-0012"><h3 class="pmc_sec_title">7.3. Assessment of Treatment‐Induced Metabolic Changes</h3>
<p>Metabolic changes in response to different treatments were monitored using <sup>1</sup>H MRS, with a PRESS voxel positioned on T<sub>2</sub>‐weighted images, as shown in Figure <a href="#nbm70113-fig-0002" class="usa-link">2</a>. By Day 3, no significant differences in tCho/tCr ratio across treatment groups were observed; however, by Day 6, the combination therapy group exhibited a 36% reduction in tCho/tCr ratio compared with the saline control group (1.59 <em>±</em> 0.26 vs. 2.28 <em>±</em> 0.69; <em>p</em> = 0.09, Table <a href="#nbm70113-supitem-0004" class="usa-link">S1</a>, Figure <a href="#nbm70113-fig-0003" class="usa-link">3A</a>). tCho/NAA ratios were also computed as they indicate neuronal integrity as an additional dimension, particularly relevant in GBM studies where NAA levels often decrease due to neuronal loss or damage. Similar to tCho/tCr, tCho/NAA was 28% and 26% lower in the TMZ‐alone and combination groups, respectively, compared with the control group (1.26 <em>±</em> 0.15 and 1.29 <em>±</em> 0.21 vs. 1.65 <em>±</em> 0.58) at Day 3. On Day 6, tCho/NAA was significantly lower in the combination group relative to the control group (48% lower; 1.24 <em>±</em> 0.21 vs. 1.92 <em>±</em> 0.50; <em>p</em> = 0.03, Table <a href="#nbm70113-tbl-0001" class="usa-link">1</a>, Figure <a href="#nbm70113-fig-0003" class="usa-link">3B</a>). mI/tCr ratio was significantly lower in TMZ and TMZ + MN58b groups compared with the control group at Day 3 (0.97 <em>±</em> 0.39 and 0.82 <em>±</em> 0.27 vs. 1.50 <em>±</em> 0.64; <em>p</em> = 0.04 and 0.02, respectively), and Day 6 (1.08 <em>±</em> 0.22 and 0.90 <em>±</em> 0.20 vs. 2.37 <em>±</em> 1.20; <em>p</em> = 0.01 and 0.008, respectively, Table <a href="#nbm70113-tbl-0001" class="usa-link">1</a>, Figure <a href="#nbm70113-fig-0003" class="usa-link">3C</a>). Lip + Lac/tCr ratio was also significantly lower in the TMZ + MN58b group compared with the control group on both Day 3 (1.80 <em>±</em> 0.60 vs. 3.71 <em>±</em> 1.81; <em>p</em> = 0.04) and Day 6 (1.82 <em>±</em> 0.52 vs. 7.13 <em>±</em> 2.3; <em>p</em> = 0.005, Table <a href="#nbm70113-tbl-0001" class="usa-link">1</a>, Figure <a href="#nbm70113-fig-0003" class="usa-link">3D</a>), with a less pronounced decline in the MN58b‐alone group and a notable but non‐significant trend observed in the TMZ group. No significant changes in the Glx/tCr ratio were detected across all treatment cohorts relative to the control group at any time point (<em>p</em> &gt; 0.05, Table <a href="#nbm70113-supitem-0004" class="usa-link">S1</a>, Figure <a href="#nbm70113-fig-0003" class="usa-link">3E</a>).</p>
<figure class="fig xbox font-sm" id="nbm70113-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e12/12319478/cd7ac3c2ee52/NBM-38-e70113-g007.jpg" loading="lazy" id="jats-graphic-5" height="428" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/nbm70113-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A–G) T2‐weighted image (A) displaying the voxel position (highlighted region in dashed red) used for MRS acquisition within the tumor region. Representative MR spectra (B–G) from tumor‐bearing mice at baseline (Day 0), Day 3, and Day 6. Example spectra from a control mouse (B–D) and an MN58b + TMZ treated mouse (E–G) are shown. Resonances typically seen in the tumors have been labelled (Lip + Lac, NAA, Glx, tCr, tCho, and mI).</p></figcaption></figure><figure class="fig xbox font-sm" id="nbm70113-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e12/12319478/483f0bacdc38/NBM-38-e70113-g001.jpg" loading="lazy" id="jats-graphic-7" height="460" width="709" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/nbm70113-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A–E) Percentage change (relative to baseline) in metabolite ratios following drug treatment. (A) tCho/tCr, (B) tCho/NAA, (C) mI/tCr, (D) Lip + Lac/tCr, and (E) Glx/tCr. The asterisk indicates the difference between groups reached a significance level of <em>p</em> &lt; 0.05.</p></figcaption></figure><section class="tw xbox font-sm" id="nbm70113-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Summary of key IVIM‐DWI and MRS parameters at baseline, Day 3, and Day 6. Data are presented as the mean ± standard deviation. The <em>p</em>‐value for the comparison with the control group is presented in brackets. The asterisk indicates the difference between groups where <em>p</em> &lt; 0.05.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom"><tr style="border-bottom:solid 1px #000000">
<th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1"></th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Control</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">MN58b</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">TMZ</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">TMZ + MN58b</th>
</tr></thead>
<tbody valign="top">
<tr><td colspan="5" align="left" valign="top" rowspan="1">D (10<sup>−3</sup> mm<sup>2</sup>/s)</td></tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.35 ± 0.44</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.36 ± 0.41 (0.99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.52 ± 0.32 (0.52)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.41 ± 0.46 (0.71)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 3</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.26 ± 0.21</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.35 ± 0.24 (0.79)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.40 ± 0.27 (0.28)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.46 ± 0.28 (0.26)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 6</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.25 ± 0.27</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.33 ± 0.23 (0.95)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.51 ± 0.30 (0.24)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.68 ± 0.32 (*0.03)</td>
</tr>
<tr><td colspan="5" align="left" valign="top" rowspan="1">tCho/NAA</td></tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.35 ± 0.29</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.18 ± 0.20 (0.26)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.24 ± 0.19 (0.65)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.31 ± 0.49 (0.95)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 3</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.65 ± 0.58</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.66 ± 0.41 (&gt; 0.99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.26 ± 0.15 (0.76)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.29 ± 0.21 (0.82)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 6</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.92 ± 0.50</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.72 ± 0.64 (0.92)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.34 ± 0.19 (0.26)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.24 ± 0.21 (*0.03)</td>
</tr>
<tr><td colspan="5" align="left" valign="top" rowspan="1">mI/tCr</td></tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 0</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.19 ± 0.54</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.92 ± 0.54 (0.78)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.73 ± 0.24 (0.09)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.60 ± 0.16 (0.08)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 3</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.50 ± 0.64</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.45 ± 0.85 (0.99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.97 ± 0.39 (*0.04)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.82 ± 0.27 (*0.02)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 6</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.37 ± 1.20</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.85 ± 0.83 (0.73)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.08 ± 0.22 (*0.01)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.90 ± 0.20 (*0.008)</td>
</tr>
<tr><td colspan="5" align="left" valign="top" rowspan="1">Lip + Lac/tCr</td></tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 0</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.51 ± 1.16</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.07 ± 0.82 (0.72)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.94 ± 1.27 (0.70)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.72 ± 1.12 (0.78)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 3</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.71 ± 1.91</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.75 ± 2.01 (&gt; 0.99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.90 ± 1.69 (0.81)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.80 ± 0.60 (*0.04)</td>
</tr>
<tr>
<td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Day 6</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.13 ± 2.49</td>
<td align="center" valign="top" rowspan="1" colspan="1">5.51 ± 3.62 (0.72)</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.58 ± 3.33 (0.09)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.82 ± 0.52 (*0.005)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Mitotic index (Day 6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">7.40 ± 0.80</td>
<td align="center" valign="top" rowspan="1" colspan="1">3.90 ± 0.65 (0.64)</td>
<td align="center" valign="top" rowspan="1" colspan="1">4.10 ± 0.70 (0.75)</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.26 ± 1.50 (*0.01)</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">% apoptosis (Day 6)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.63 ± 0.45</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.30 ± 0.14 (0.45)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.24 ± 0.11 (0.34)</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.21 ± 0.13 (0.30)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/nbm70113-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Overall, these metabolic changes, particularly the reductions in the tCho/NAA, mI/tCr, and Lip + Lac/tCr, highlight the ability of MRS to capture early treatment‐induced metabolic alterations.</p></section><section id="nbm70113-sec-0013"><h3 class="pmc_sec_title">7.4. Changes in IVIM‐DWI Parameters Following Drug Treatment</h3>
<p>Figure <a href="#nbm70113-fig-0004" class="usa-link">4</a> shows representative parametric maps from the DWI data from a tumor bearing mouse including ADC (Figure <a href="#nbm70113-fig-0004" class="usa-link">4A</a>), <em>D</em> (Figure <a href="#nbm70113-fig-0004" class="usa-link">4B</a>), <em>D*</em> (Figure <a href="#nbm70113-fig-0004" class="usa-link">4C</a>) and <em>f</em> (Figure <a href="#nbm70113-fig-0004" class="usa-link">4D</a>). The red outline shows the ROI, which was used to calculate the individual parametric values. No significant differences in ADC values were observed between treatment groups and control group at any time point (<em>p</em> &gt; 0.05); however, the MN58b + TMZ group exhibited an upward trend in ADC values by Day 6 compared with the other cohorts (Table <a href="#nbm70113-supitem-0004" class="usa-link">S1</a>, Figure <a href="#nbm70113-fig-0005" class="usa-link">5A</a>). Similarly, animals in treated groups demonstrated a trend of higher pure diffusion coefficient (<em>D</em>) values compared with the control group by Day 6, with MN58b + TMZ therapy group demonstrating significantly higher <em>D</em> values than the control group (1.68 <em>±</em> 0.32 <em>×</em> 10<sup>
<em>−</em>3</sup> mm<sup>2</sup>/s vs. 1.25 <em>±</em> 0.27 <em>×</em> 10<sup>
<em>−</em>3</sup> mm<sup>2</sup>/s; <em>p</em> = 0.03, Table <a href="#nbm70113-tbl-0001" class="usa-link">1</a>, Figure <a href="#nbm70113-fig-0005" class="usa-link">5B</a>). No significant differences were detected in the pseudo‐diffusion coefficient (<em>D*</em>) or perfusion fraction (<em>f</em>) values across any of treatment groups compared with the saline control group at any time point (<em>p</em> &gt; 0.05, Table <a href="#nbm70113-supitem-0004" class="usa-link">S1</a>, Figure <a href="#nbm70113-fig-0005" class="usa-link">5C,D</a>).</p>
<figure class="fig xbox font-sm" id="nbm70113-fig-0004"><h4 class="obj_head">FIGURE 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e12/12319478/7e5db4bd80db/NBM-38-e70113-g005.jpg" loading="lazy" id="jats-graphic-9" height="395" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/nbm70113-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A–D) Representative intravoxel incoherent motion (IVIM) parameter maps illustrating the apparent diffusion coefficient (ADC), pure diffusion coefficient (<em>D</em>), pseudo‐diffusion coefficient (<em>D*</em>), and perfusion fraction (<em>f</em>). The tumor region of interest (ROI) is delineated in magenta.</p></figcaption></figure><figure class="fig xbox font-sm" id="nbm70113-fig-0005"><h4 class="obj_head">FIGURE 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e12/12319478/913d7dd4f76a/NBM-38-e70113-g006.jpg" loading="lazy" id="jats-graphic-11" height="399" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/nbm70113-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A–D) Box plots illustrating the percent change in the IVIM‐DWI parameters, ADC, <em>D</em>, <em>D*</em>, and <em>f</em>, with time with respect to Day 0 for all groups. The asterisk indicates the difference between groups where <em>p</em> &lt; 0.05.</p></figcaption></figure></section><section id="nbm70113-sec-0014"><h3 class="pmc_sec_title">7.5. Histopathological Analysis</h3>
<p>Histological analysis for proliferation (mitotic index, measured through H&amp;E staining) and apoptosis (caspase‐3 expression) was performed after the final imaging time point (Day 6) on three animals from each group. Representative stains from each group of animals are shown in Figure <a href="#nbm70113-fig-0006" class="usa-link">6A–H</a>. While the mitotic index was significantly lower in the MN58b + TMZ therapy group compared with the saline group (1.26 <em>±</em> 1.50 vs. 7.40 <em>±</em> 0.80; <em>p</em> = 0.01, Table <a href="#nbm70113-tbl-0001" class="usa-link">1</a>, Figure <a href="#nbm70113-fig-0006" class="usa-link">6I</a>), no significant differences were observed in the % caspase‐3 positive cells among any of the treated groups compared with the saline control group (<em>p</em> &gt; 0.05, Table <a href="#nbm70113-tbl-0001" class="usa-link">1</a>, Figure <a href="#nbm70113-fig-0006" class="usa-link">6J</a>).</p>
<figure class="fig xbox font-sm" id="nbm70113-fig-0006"><h4 class="obj_head">FIGURE 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e12/12319478/d4cd55376823/NBM-38-e70113-g004.jpg" loading="lazy" id="jats-graphic-13" height="528" width="709" alt="FIGURE 6"></p>
<div class="p text-right font-secondary"><a href="figure/nbm70113-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A–J) Representative H&amp;E images from the four experimental groups. (A–D) Representative high‐power fields close to the normal brain parenchyma (*) with highlighted mitotic figures (green circles) for saline (A), MN58b (B), TMZ (C), and MN58b + TMZ (D), hematoxylin–eosin, 400×. (E–H) Representative examples of positive cells for caspase‐3 expression (arrowhead) for saline (E), MN58b (F), TMZ (G), and MN58b + TMZ (H). Scalebars: 50 μm. Mitotic index (I) and percentage positive apoptotic cells (J) measurements were assessed from the tumor margins of three animals from each treatment group.</p></figcaption></figure></section></section><section id="nbm70113-sec-0015"><h2 class="pmc_sec_title">8. Discussion</h2>
<p>In this study, we observed combinatorial effects due to MN58b, a ChoK<em>α</em> inhibitor, and TMZ in an orthotopic GBM mouse model. The combination therapy resulted in significant metabolic and microstructural changes within the tumor, which were detectable using MRS and IVIM‐DWI prior to any observable changes in tumor volume. Specifically, the combination therapy demonstrated marked reductions in the tCho/NAA, mI/tCr, and Lip + Lac/tCr ratios relative to the control group, alongside a significant increase in D values, indicative of reduced tumor proliferation and lower cellularity. The combination therapy led to significantly increased survival compared with the control group.</p>
<p>Accurate and prompt diagnosis of tumor progression versus treatment response in patients with GBM is crucial for proper salvage therapy. MR techniques such as MRS and IVIM‐DWI effectively detect early treatment responses, which may be critical for effective treatment decisions. Importantly, tumor volume measurements, typically used in radiological assessments such as the response assessment in neuro‐oncology (RANO) criteria, lag behind treatment‐induced metabolic and microstructural changes. While RANO criteria provide a framework for assessing disease progression in brain tumors, they rely heavily on radiological measurements like tumor volume and contrast enhancement [<a href="#nbm70113-bib-0026" class="usa-link" aria-describedby="nbm70113-bib-0026">26</a>]. RANO criteria often fail to differentiate pseudo‐response (quick reduction in contrast enhancement without true tumoricidal effect) as well as pseudo‐progression (transient treatment‐related increase in contrast enhancement suggestive of treatment response) [<a href="#nbm70113-bib-0005" class="usa-link" aria-describedby="nbm70113-bib-0005">5</a>]. Pseudo‐progression is often associated with TMZ therapy. For example, metabolic changes detected by MR spectroscopy, such as alterations in choline‐containing compounds, have been used to differentiate true tumor progression from pseudoprogression in GBM patients, thereby guiding clinical management. These instances underscore the clinical relevance of metabolic imaging in informing treatment strategies [<a href="#nbm70113-bib-0044" class="usa-link" aria-describedby="nbm70113-bib-0044">44</a>]. Conversely, pseudo‐response is typically linked to anti‐angiogenic treatments, such as bevacizumab [<a href="#nbm70113-bib-0006" class="usa-link" aria-describedby="nbm70113-bib-0006">6</a>]. Although PET can aid in brain lesion assessment, its limited availability restricts clinical use [<a href="#nbm70113-bib-0003" class="usa-link" aria-describedby="nbm70113-bib-0003">3</a>, <a href="#nbm70113-bib-0004" class="usa-link" aria-describedby="nbm70113-bib-0004">4</a>]. For example, the PET tracer L‐[methyl‐<sup>11</sup>C] methionine is effective in diagnosing recurrence but requires a cyclotron to synthesize the radio‐isotope [<a href="#nbm70113-bib-0025" class="usa-link" aria-describedby="nbm70113-bib-0025">25</a>]. A recent meta‐analysis reported that MR spectroscopy has the highest diagnostic accuracy, followed by MRI methods like DSC and DWI, outperforming traditional MR imaging in detecting treatment‐induced changes [<a href="#nbm70113-bib-0025" class="usa-link" aria-describedby="nbm70113-bib-0025">25</a>].</p>
<p>TMZ works by causing DNA methylation, which damages DNA, alters the cell cycle, and induces apoptosis, autophagy, and senescence [<a href="#nbm70113-bib-0008" class="usa-link" aria-describedby="nbm70113-bib-0008">8</a>]. Tumors expressing O6‐methylguanine‐DNA‐methyltransferase (MGMT) may resist TMZ‐induced cell death as MGMT repairs TMZ‐induced DNA methylation [<a href="#nbm70113-bib-0007" class="usa-link" aria-describedby="nbm70113-bib-0007">7</a>]. Even responsive tumors can develop resistance over time [<a href="#nbm70113-bib-0007" class="usa-link" aria-describedby="nbm70113-bib-0007">7</a>]. Research shows hypoxia supports TMZ resistance in GBM, while hyperoxia can sensitize tumors [<a href="#nbm70113-bib-0011" class="usa-link" aria-describedby="nbm70113-bib-0011">11</a>]. Hypoxia also contributes to resistance to anti‐angiogenic treatments, including bevacizumab, a vascular endothelial growth factor (VEGF) inhibitor [<a href="#nbm70113-bib-0009" class="usa-link" aria-describedby="nbm70113-bib-0009">9</a>]. Immunotherapies such as nivolumab (NIVO) have shown effectiveness against brain metastases from melanoma and increased survival in cancers like lung and kidney. However, NIVO combined with radiotherapy offers a lower survival benefit compared with TMZ combined with radiotherapy, making NIVO an inadequate substitute for TMZ [<a href="#nbm70113-bib-0014" class="usa-link" aria-describedby="nbm70113-bib-0014">14</a>]. Thus, there is an urgent need for new therapies to overcome TMZ‐related treatment resistance.</p>
<p>Choline is essential for cell membrane biosynthesis via the Kennedy pathway. Phosphocholine (PC) is a promising oncometabolite, which is dysregulated in many cancers, including endometrial, lung, breast, and prostate [<a href="#nbm70113-bib-0017" class="usa-link" aria-describedby="nbm70113-bib-0017">17</a>]. Abnormal choline metabolism, driven by ChoK<em>α</em> upregulation, is linked to tumor growth and drug resistance [<a href="#nbm70113-bib-0019" class="usa-link" aria-describedby="nbm70113-bib-0019">19</a>, <a href="#nbm70113-bib-0021" class="usa-link" aria-describedby="nbm70113-bib-0021">21</a>]. ChoK<em>α</em>, the first enzyme in the Kennedy pathway, phosphorylates choline into PC, with elevated PC indicating tumor progression [<a href="#nbm70113-bib-0017" class="usa-link" aria-describedby="nbm70113-bib-0017">17</a>]. In brain tumors, higher ChoK<em>α</em> expression correlates with grade and malignancy [<a href="#nbm70113-bib-0017" class="usa-link" aria-describedby="nbm70113-bib-0017">17</a>, <a href="#nbm70113-bib-0020" class="usa-link" aria-describedby="nbm70113-bib-0020">20</a>]. Targeting ChoK<em>α</em> shows promise in cancer therapies, with MRS‐based assessment and ChoK<em>α</em> inhibition yielding positive outcomes in breast cancer and glioblastoma models [<a href="#nbm70113-bib-0017" class="usa-link" aria-describedby="nbm70113-bib-0017">17</a>, <a href="#nbm70113-bib-0023" class="usa-link" aria-describedby="nbm70113-bib-0023">23</a>, <a href="#nbm70113-bib-0024" class="usa-link" aria-describedby="nbm70113-bib-0024">24</a>]. Our group has recently demonstrated reductions in perfusion, permeability, and increased necrosis in F98 tumors after treatment with JAS239, a 2nd generation ChoK<em>α</em> inhibitor [<a href="#nbm70113-bib-0044" class="usa-link" aria-describedby="nbm70113-bib-0044">44</a>]. A previous study from our group also reported that JAS239 reduced tCho concentrations and tCho/tCr and tCho/NAA ratios in rodent GBM models, indicating metabolic changes in response to ChoK<em>α</em> inhibition [<a href="#nbm70113-bib-0024" class="usa-link" aria-describedby="nbm70113-bib-0024">24</a>]. ChoKα inhibition by MN58b disrupts phosphatidylcholine synthesis, which alters membrane lipid composition and cellular stress. This metabolic stress may impair DNA repair mechanisms, potentially sensitizing tumor cells to the DNA‐damaging effects of TMZ. Thus, combining MN58b and TMZ could enhance therapeutic efficacy by simultaneously targeting membrane metabolism and DNA integrity [<a href="#nbm70113-bib-0022" class="usa-link" aria-describedby="nbm70113-bib-0022">22</a>, <a href="#nbm70113-bib-0023" class="usa-link" aria-describedby="nbm70113-bib-0023">23</a>, <a href="#nbm70113-bib-0024" class="usa-link" aria-describedby="nbm70113-bib-0024">24</a>]. The tCho/NAA ratio is a recognized biomarker for tumor proliferation and malignancy in glioblastoma, with elevated tCho levels typically indicating increased membrane turnover in rapidly growing tumors [<a href="#nbm70113-bib-0017" class="usa-link" aria-describedby="nbm70113-bib-0017">17</a>, <a href="#nbm70113-bib-0020" class="usa-link" aria-describedby="nbm70113-bib-0020">20</a>]. In this study, by Day 6, the TMZ + MN58b group demonstrated significantly lower tCho/NAA as well as increased survival compared with the control group, suggesting an effective inhibition of tumor proliferation via cell cycle arrest, potentially due to the combined therapeutic effects of MN58b + TMZ on cell cycle progression. MN58b has been shown to inhibit ChoKα's catalytic activity but does not significantly interfere with its protein stability in all models [<a href="#nbm70113-bib-0045" class="usa-link" aria-describedby="nbm70113-bib-0045">45</a>]. While MN58b is a known ChoKα inhibitor, its effect on tCho levels can vary depending on the tumor model, drug dosage, and degree of ChoKα inhibition achieved. In our study, the absence of a significant reduction in tCho/tCr or tCho/NAA in the MN58b monotherapy group may be due to compensatory metabolic adaptations, subthreshold pharmacodynamic effects at the examined time point, or tumor heterogeneity. Our previous study reported such an observation where the GL261 mouse model exhibited a modest effect in response to JAS239 given at the same treatment regimen of MN58b, indicating the aggressive nature of the GL261 mouse model [<a href="#nbm70113-bib-0024" class="usa-link" aria-describedby="nbm70113-bib-0024">24</a>]. In our study, the tCho/NAA reduction observed in the combination group may reflect partial recovery of surrounding neuronal integrity or differential effects on NAA relative to tCho. The lack of change in tCho/tCr may imply that Cr levels remained stable or were slightly elevated, offsetting any subtle tCho reduction. A lower mI/tCr ratio in the combination therapy group on Days 3 and 6 suggests decreased astrocytic activity and increased cellular stress within the TME. This is consistent with prior research, which indicated treatment‐induced disruption of metabolic pathways linked to glial proliferation and stress responses in GBMs [<a href="#nbm70113-bib-0024" class="usa-link" aria-describedby="nbm70113-bib-0024">24</a>, <a href="#nbm70113-bib-0046" class="usa-link" aria-describedby="nbm70113-bib-0046">46</a>, <a href="#nbm70113-bib-0047" class="usa-link" aria-describedby="nbm70113-bib-0047">47</a>]. The resonance at ~3.56 ppm includes contributions from both myo‐inositol and glycine. While myo‐inositol is associated with glial activity and osmoregulation, glycine levels are elevated in tumors and correlate with proliferation. The observed decrease of the peak at 3.56 ppm may thus also reflect a reduction in glycine due to the anti‐proliferative effects of the drugs. Future studies using both short and long echo time MRS could help differentiate between these metabolites and better describe their contribution to treatment response assessment. These would also aid in better differentiation of lactate from mobile lipids and macromolecules. The significant reduction in Lip + Lac/tCr ratio in the combination therapy group was observed as early as Day 3 and persisted through Day 6, suggesting reduced glycolytic activity and lipid turnover and storage due to effective therapeutic action, as reported earlier [<a href="#nbm70113-bib-0048" class="usa-link" aria-describedby="nbm70113-bib-0048">48</a>]. The observed decrease may be due to a reduction in lipid and glycolytic metabolism because the PRESS spectroscopy sequence used in this study cannot differentiate between the overlapping resonances of lipids from lactate. For future studies, utilizing a longer echo time in MRS or lactate‐edited pulse sequences may aid in differentiating lactate and lipid signals, potentially allowing for a clearer assessment of treatment response and metabolic shifts within the tumor [<a href="#nbm70113-bib-0049" class="usa-link" aria-describedby="nbm70113-bib-0049">49</a>]. Subramani et al. observed that TMZ treatment reduced the <sup>13</sup>C MRS‐detectable pyruvate‐to‐lactate conversion in wild‐type IDH glioma but did not affect <sup>1</sup>H MRS‐detectable Glx (glutamine and glutamate). In contrast, mutant IDH1 tumors demonstrated increased Glx in response to TMZ [<a href="#nbm70113-bib-0050" class="usa-link" aria-describedby="nbm70113-bib-0050">50</a>]. Similarly, Radoul et al. reported elevated Glx following the administration of IDH1 inhibitors in IDH1‐mutant glioma models [<a href="#nbm70113-bib-0051" class="usa-link" aria-describedby="nbm70113-bib-0051">51</a>]. However, Bhaduri et al. found no significant change in Glx in GBM models treated with a CKI [<a href="#nbm70113-bib-0024" class="usa-link" aria-describedby="nbm70113-bib-0024">24</a>]. In our study, the Glx/tCr ratio remained unchanged across treatment groups, suggesting that changes in Glx levels may be treatment or cell‐line‐specific.</p>
<p>In our study, <em>D</em> values were significantly elevated in the TMZ + MN58b group, indicating lower cellularity and increased motion of water molecules in the treatment group, suggesting a successful therapeutic response. This observation aligns with findings from prior studies in various cancers, where increased <em>D</em> values have been linked to treatment response, including head‐and‐neck cancer, brain metastases, and hepatocellular carcinoma [<a href="#nbm70113-bib-0052" class="usa-link" aria-describedby="nbm70113-bib-0052">52</a>, <a href="#nbm70113-bib-0053" class="usa-link" aria-describedby="nbm70113-bib-0053">53</a>, <a href="#nbm70113-bib-0054" class="usa-link" aria-describedby="nbm70113-bib-0054">54</a>]. While ADC values also demonstrated an upward trend in the combination therapy group in our study, this change was not as significant as the increase observed in <em>D</em>. These results highlight the sensitivity of IVIM‐DWI derived <em>D</em> as a marker for cellularity changes in response to treatment, offering a more accurate assessment of therapeutic impact than ADC. No significant changes in perfusion‐related IVIM‐DWI parameters <em>D*</em> and <em>f</em> were observed across all treated groups, consistent with the literature [<a href="#nbm70113-bib-0052" class="usa-link" aria-describedby="nbm70113-bib-0052">52</a>, <a href="#nbm70113-bib-0053" class="usa-link" aria-describedby="nbm70113-bib-0053">53</a>, <a href="#nbm70113-bib-0054" class="usa-link" aria-describedby="nbm70113-bib-0054">54</a>]. This suggests that MN58b and TMZ, either alone or in combination, did not significantly impact tumor vasculature. In contrast, antiangiogenic treatments such as bevacizumab significantly reduce <em>D*</em> and <em>f</em> values in glioma models, highlighting the potential role of combining vascular‐targeted therapies with metabolic inhibitors like MN58b for better therapeutic outcomes [<a href="#nbm70113-bib-0055" class="usa-link" aria-describedby="nbm70113-bib-0055">55</a>]. In this study, IVIM‐DWI was chosen for its ability to capture both diffusivity and perfusion fraction, providing combined microstructural and vascular characterization within a single acquisition protocol. However, because only microstructural changes were detected, future studies could benefit from exploring complementary diffusion techniques such as DTI and DKI, which offer more detailed microstructural metrics, including anisotropy and kurtosis, particularly at higher b‐values, to further characterize tissue heterogeneity. Additionally, the potential value of incorporating other endogenous contrast MRI methods, such as ASL, could be investigated alongside IVIM‐DWI to provide a non‐invasive complement or alternative for a more comprehensive assessment of tumor vasculature.</p>
<p>Our imaging‐based findings were further supported by the reduced mitotic index in the combination therapy group, which agrees with prior studies [<a href="#nbm70113-bib-0024" class="usa-link" aria-describedby="nbm70113-bib-0024">24</a>, <a href="#nbm70113-bib-0049" class="usa-link" aria-describedby="nbm70113-bib-0049">49</a>]. However, we did not observe any significant changes in the degree of apoptosis (caspase‐3) in the combination treatment group, indicating an absence of marked apoptosis due to the treatment. This probably indicates an induced cytostatic effect (cell cycle arrest) rather than direct cytotoxicity (apoptosis), which was also reported in tumors treated with TMZ [<a href="#nbm70113-bib-0056" class="usa-link" aria-describedby="nbm70113-bib-0056">56</a>] and a CKI [<a href="#nbm70113-bib-0057" class="usa-link" aria-describedby="nbm70113-bib-0057">57</a>]. We do acknowledge that our observations are based on only three samples per group, as we were unable to process additional samples due to increased cost as well as using the tumor tissue for another study.</p>
<p>Although promising, this study has certain limitations. Firstly, the dose regimen used for MN58b may not have been optimal for the GL261 model, as it was chosen based on previous studies on breast cancer [<a href="#nbm70113-bib-0054" class="usa-link" aria-describedby="nbm70113-bib-0054">54</a>] and a rat model [<a href="#nbm70113-bib-0023" class="usa-link" aria-describedby="nbm70113-bib-0023">23</a>] of GBM. Second, the aggressive nature of the GL261 tumor model necessitated a short imaging window, limiting the ability to assess the longer‐term effects of the combination therapy.</p>
<p>Future studies should focus on optimizing the dosing regimen of MN58b and exploring its efficacy as a monotherapy or in combination with other treatments like radiotherapy or additional targeted therapies like anti‐angiogenic agents and glycolytic inhibitors like lonidamine [<a href="#nbm70113-bib-0058" class="usa-link" aria-describedby="nbm70113-bib-0058">58</a>]. Expanding the imaging window could provide more robust insights into the therapeutic effects of the treatments. While incorporating complementary imaging techniques such as DCE‐MRI would provide a more comprehensive understanding of changing tumor perfusion dynamics during therapy, ASL may serve as a useful complement or alternative to IVIM for assessing vascular characteristics, particularly when avoiding contrast agents is desirable. These data were obtained from chemically induced rodent GBM cell lines, which rapidly form large tumors, and thus, extrapolation to the human context should be approached with caution. In future studies, the use of human‐derived xenograft models (e.g., U251) could be considered, as they may better reflect the time course of tumor formation and the therapy resistance observed in human GBM. However, PDX models have their own limitations as they are grown in immune‐deficient rodents, and thus the tumor‐immune cell interaction or the TME observed in human tumors cannot be truly replicated in these models either.</p></section><section id="nbm70113-sec-0016"><h2 class="pmc_sec_title">9. Conclusion</h2>
<p>
<sup>1</sup>H MRS and IVIM‐DWI may be valuable non‐invasive tools for monitoring treatment‐induced changes in tumors, providing insights into metabolic, diffusion, and perfusion characteristics that report on the effectiveness of cancer treatments. Targeting ChoK<em>α</em> and inducing DNA damage in tumor cells with TMZ offers a promising dual therapeutic strategy for glioblastoma treatment. As both drugs are sufficiently bioavailable within the GBM to have a measurable impact and target disparate, unrelated cellular targets, this approach can potentially enhance treatment and reduce drug resistance of the notoriously TMZ‐resistant GBM.</p></section><section id="nbm70113-sec-0018"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="sec18"><h2 class="pmc_sec_title">Supporting information</h2>
<section class="sm xbox font-sm" id="nbm70113-supitem-0001"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12319478/bin/NBM-38-e70113-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">NBM-38-e70113-s001.docx</a><sup> (1.1MB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="nbm70113-supitem-0002"><div class="caption p"><p>
<strong>Figure S1:</strong> A representative <sup>1</sup>H MRS spectrum illustrating the fitting performance from a 9L tumor‐bearing rat (original spectra in blue, fitted spectra in red, and residual in black). This figure is from on our previously published work by Bhaduri et al. [25], which used the same acquisition and quantification pipeline for GL261 glioma models reported in this paper.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12319478/bin/NBM-38-e70113-s004.tiff" data-ga-action="click_feat_suppl" class="usa-link">NBM-38-e70113-s004.tiff</a><sup> (116.6KB, tiff) </sup>
</div></div></section><section class="sm xbox font-sm" id="nbm70113-supitem-0003"><div class="caption p"><p>
<strong>Figure S2:</strong> Examples of the digital analysis workflow for caspase‐3: (A) Low power magnification of tumor (*) surrounded by normal parenchyma (**) identified as region of interest (ROI—yellow line). Scalebar: 800 μm. (B) High power magnification of the segmentation mask for caspase‐3 negative (blue) and positive (red) cells. Scalebar: 50 μm.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12319478/bin/NBM-38-e70113-s003.tiff" data-ga-action="click_feat_suppl" class="usa-link">NBM-38-e70113-s003.tiff</a><sup> (984.6KB, tiff) </sup>
</div></div></section><section class="sm xbox font-sm" id="nbm70113-supitem-0004"><div class="caption p"><p>
<strong>Table S1:</strong> Summary of non‐significant parameters at baseline, Day 3, and Day 6. Data are presented as the mean ± standard deviation. The <em>p</em>‐value for the comparison with the control group is presented in brackets.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12319478/bin/NBM-38-e70113-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">NBM-38-e70113-s002.docx</a><sup> (16.4KB, docx) </sup>
</div></div></section></section><section id="nbm70113-sec-0017" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors acknowledge the use of the Centre for Preclinical Imaging (CPI) imaging facilities provided by Liverpool Shared Research Facilities, Faculty of Health and Life Sciences, University of Liverpool, and Histology laboratory, Leahurst Campus, University of Liverpool. Tareq Alrashidi has been funded by a PhD studentship grant from the Ministry of Education, Saudi Arabia. Elisabeth Non Gash was funded by a PhD studentship from the Isle of Man Anti‐Cancer Research Charity. Sungheon G. Kim, Weill Cornell Medical College, is acknowledged for providing the GL261 cells. Dr. Sultan Naif Aljuraysi, King Saud University, Saudi Arabia, and former PhD student at the University of Liverpool, is acknowledged for help with drug formulations.</p></section><section id="notes1"><p>

Alrashidi T., Bhaduri S., Gash E., et al., “Evaluating the Combined Effect of a Choline Kinase Inhibitor and Temozolomide Therapy in a Mouse Model of Glioblastoma Using <sup>1</sup>H MR Spectroscopy and IVIM‐DWI,” NMR in Biomedicine
38, no. 9 (2025): e70113, 10.1002/nbm.70113.

</p>
<section id="nbm70113-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="nbm70113-note-0001"><p>
<strong>Funding:</strong> This work was supported by the Ministry of Education, Kingdom of Saudi Arabia, and the Isle of Man Anti‐Cancer Research Charity.</p></div></div></section></section><section id="nbm70113-sec-0020"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section><section id="nbm70113-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="nbm70113-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="nbm70113-bib-0001">
<span class="label">1.</span><cite>
Louis D. N., Perry A., Wesseling P., et al., “The 2021 WHO Classification of Tumors of the Central Nervous System: A Summary,” Neuro‐Oncology
23, no. 8 (2021): 1231–1251, 10.1093/neuonc/noab106.
</cite> [<a href="https://doi.org/10.1093/neuonc/noab106" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8328013/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34185076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%E2%80%90Oncology&amp;title=The%202021%20WHO%20Classification%20of%20Tumors%20of%20the%20Central%20Nervous%20System:%20A%20Summary&amp;author=D.%20N.%20Louis&amp;author=A.%20Perry&amp;author=P.%20Wesseling&amp;volume=23&amp;issue=8&amp;publication_year=2021&amp;pages=1231-1251&amp;pmid=34185076&amp;doi=10.1093/neuonc/noab106&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0002">
<span class="label">2.</span><cite>
Mohammed S., Dinesan M., and Ajayakumar T., “Survival and Quality of Life Analysis in Glioblastoma Multiforme With Adjuvant Chemoradiotherapy: A Retrospective Study,” Reports of Practical Oncology and Radiotherapy
27, no. 6 (2022): 1026–1036, 10.5603/RPOR.a2022.0113.
</cite> [<a href="https://doi.org/10.5603/RPOR.a2022.0113" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9826661/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36632307/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Reports%20of%20Practical%20Oncology%20and%20Radiotherapy&amp;title=Survival%20and%20Quality%20of%20Life%20Analysis%20in%20Glioblastoma%20Multiforme%20With%20Adjuvant%20Chemoradiotherapy:%20A%20Retrospective%20Study&amp;author=S.%20Mohammed&amp;author=M.%20Dinesan&amp;author=T.%20Ajayakumar&amp;volume=27&amp;issue=6&amp;publication_year=2022&amp;pages=1026-1036&amp;pmid=36632307&amp;doi=10.5603/RPOR.a2022.0113&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0003">
<span class="label">3.</span><cite>
Cha S., “Update on Brain Tumour Imaging: From Anatomy to Physiology,” American Journal of Neuroradiology
27, no. 3 (2006): 475–487.
</cite> [<a href="/articles/PMC7976984/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16551981/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=American%20Journal%20of%20Neuroradiology&amp;title=Update%20on%20Brain%20Tumour%20Imaging:%20From%20Anatomy%20to%20Physiology&amp;author=S.%20Cha&amp;volume=27&amp;issue=3&amp;publication_year=2006&amp;pages=475-487&amp;pmid=16551981&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0004">
<span class="label">4.</span><cite>
Young G. S., “Advanced MRI of Adult Brain Tumours,” Neurologic Clinics
25, no. 4 (2007): 947–973, 10.1016/j.ncl.2007.07.010.
</cite> [<a href="https://doi.org/10.1016/j.ncl.2007.07.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17964022/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurologic%20Clinics&amp;title=Advanced%20MRI%20of%20Adult%20Brain%20Tumours&amp;author=G.%20S.%20Young&amp;volume=25&amp;issue=4&amp;publication_year=2007&amp;pages=947-973&amp;pmid=17964022&amp;doi=10.1016/j.ncl.2007.07.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0005">
<span class="label">5.</span><cite>
Fèvre L., Lhermitte C., Ahle B., et al., “Pseudoprogression Versus True Progression in Glioblastoma Patients: A Multiapproach Literature Review: Part 1—Molecular, Morphological and Clinical Features,” Critical Reviews in Oncology/Hematology
157 (2021): 103188, 10.1016/j.critrevonc.2020.103188.
</cite> [<a href="https://doi.org/10.1016/j.critrevonc.2020.103188" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33307200/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Critical%20Reviews%20in%20Oncology/Hematology&amp;title=Pseudoprogression%20Versus%20True%20Progression%20in%20Glioblastoma%20Patients:%20A%20Multiapproach%20Literature%20Review:%20Part%201%E2%80%94Molecular,%20Morphological%20and%20Clinical%20Features&amp;author=L.%20F%C3%A8vre&amp;author=C.%20Lhermitte&amp;author=B.%20Ahle&amp;volume=157&amp;publication_year=2021&amp;pages=103188&amp;pmid=33307200&amp;doi=10.1016/j.critrevonc.2020.103188&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0006">
<span class="label">6.</span><cite>
Stupp R., Hegi M. E., Mason W. P., et al., “Effects of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy Alone on Survival in Glioblastoma in a Randomised Phase III Study: 5‐Year Analysis of the EORTC‐NCIC Trial,” Lancet Oncology
10, no. 5 (2009): 459–466, 10.1016/S1470-2045(09)70025-7.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(09)70025-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19269895/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncology&amp;title=Effects%20of%20Radiotherapy%20With%20Concomitant%20and%20Adjuvant%20Temozolomide%20Versus%20Radiotherapy%20Alone%20on%20Survival%20in%20Glioblastoma%20in%20a%20Randomised%20Phase%20III%20Study:%205%E2%80%90Year%20Analysis%20of%20the%20EORTC%E2%80%90NCIC%20Trial&amp;author=R.%20Stupp&amp;author=M.%20E.%20Hegi&amp;author=W.%20P.%20Mason&amp;volume=10&amp;issue=5&amp;publication_year=2009&amp;pages=459-466&amp;pmid=19269895&amp;doi=10.1016/S1470-2045(09)70025-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0007">
<span class="label">7.</span><cite>
Agnihotri S., Gajadhar A. S., Ternamian C., et al., “Alkylpurine–DNA–<em>N</em>‐Glycosylase Confers Resistance to Temozolomide in Xenograft Models of Glioblastoma Multiforme and Is Associated With Poor Survival in Patients,” Journal of Clinical Investigation
122, no. 1 (2011): 782.</cite> [<a href="https://doi.org/10.1172/JCI59334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3248301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22156195/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Investigation&amp;title=Alkylpurine%E2%80%93DNA%E2%80%93N%E2%80%90Glycosylase%20Confers%20Resistance%20to%20Temozolomide%20in%20Xenograft%20Models%20of%20Glioblastoma%20Multiforme%20and%20Is%20Associated%20With%20Poor%20Survival%20in%20Patients&amp;author=S.%20Agnihotri&amp;author=A.%20S.%20Gajadhar&amp;author=C.%20Ternamian&amp;volume=122&amp;issue=1&amp;publication_year=2011&amp;pages=782&amp;pmid=22156195&amp;doi=10.1172/JCI59334&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0008">
<span class="label">8.</span><cite>
Ortiz R., Perazzoli G., and Cabeza L., “Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications,” Current Neuropharmacology
19, no. 4 (2021): 513–537, 10.2174/1570159x18666200626204005.
</cite> [<a href="https://doi.org/10.2174/1570159x18666200626204005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8206461/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32589560/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Current%20Neuropharmacology&amp;title=Temozolomide:%20An%20Updated%20Overview%20of%20Resistance%20Mechanisms,%20Nanotechnology%20Advances%20and%20Clinical%20Applications&amp;author=R.%20Ortiz&amp;author=G.%20Perazzoli&amp;author=L.%20Cabeza&amp;volume=19&amp;issue=4&amp;publication_year=2021&amp;pages=513-537&amp;pmid=32589560&amp;doi=10.2174/1570159x18666200626204005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0009">
<span class="label">9.</span><cite>
Fu M., Zhou Z., Huang X., et al., “Use of Bevacizumab in Recurrent Glioblastoma: A Scoping Review and Evidence Map,” BMC Cancer
23 (2023): 544, 10.1186/s12885-023-11043-6.
</cite> [<a href="https://doi.org/10.1186/s12885-023-11043-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10265794/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37316802/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=Use%20of%20Bevacizumab%20in%20Recurrent%20Glioblastoma:%20A%20Scoping%20Review%20and%20Evidence%20Map&amp;author=M.%20Fu&amp;author=Z.%20Zhou&amp;author=X.%20Huang&amp;volume=23&amp;publication_year=2023&amp;pages=544&amp;pmid=37316802&amp;doi=10.1186/s12885-023-11043-6&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0010">
<span class="label">10.</span><cite>
Yu L., Chen X., Wang L., and Chen S., “The Sweet Trap in Tumours: Aerobic Glycolysis and Potential Targets for Therapy,” Oncotarget
7, no. 25 (2016): 38908–38926, 10.18632/oncotarget.7676.
</cite> [<a href="https://doi.org/10.18632/oncotarget.7676" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5122440/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26918353/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=The%20Sweet%20Trap%20in%20Tumours:%20Aerobic%20Glycolysis%20and%20Potential%20Targets%20for%20Therapy&amp;author=L.%20Yu&amp;author=X.%20Chen&amp;author=L.%20Wang&amp;author=S.%20Chen&amp;volume=7&amp;issue=25&amp;publication_year=2016&amp;pages=38908-38926&amp;pmid=26918353&amp;doi=10.18632/oncotarget.7676&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0011">
<span class="label">11.</span><cite>
Hanahan D., “Hallmarks of Cancer: New Dimensions,” Cancer Discovery
12 (2022): 31–46, 10.1158/2159-8290.CD-21-1059.
</cite> [<a href="https://doi.org/10.1158/2159-8290.CD-21-1059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35022204/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discovery&amp;title=Hallmarks%20of%20Cancer:%20New%20Dimensions&amp;author=D.%20Hanahan&amp;volume=12&amp;publication_year=2022&amp;pages=31-46&amp;pmid=35022204&amp;doi=10.1158/2159-8290.CD-21-1059&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0012">
<span class="label">12.</span><cite>
Maher E. A., Marin‐Valencia I., Bachoo R. M., et al., “Metabolism of [U‐<sup>13</sup>C]glucose in Human Brain Tumours <em>In Vivo</em>
,” NMR in Biomedicine
25, no. 11 (2012): 1234–1278, 10.1002/nbm.2794.
</cite> [<a href="https://doi.org/10.1002/nbm.2794" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3406255/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22419606/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NMR%20in%20Biomedicine&amp;title=Metabolism%20of%20%5BU%E2%80%9013C%5Dglucose%20in%20Human%20Brain%20Tumours%20In%20Vivo&amp;author=E.%20A.%20Maher&amp;author=I.%20Marin%E2%80%90Valencia&amp;author=R.%20M.%20Bachoo&amp;volume=25&amp;issue=11&amp;publication_year=2012&amp;pages=1234-1278&amp;pmid=22419606&amp;doi=10.1002/nbm.2794&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0013">
<span class="label">13.</span><cite>
Mashimo T., Pichumani K., Vemireddy V., et al., “Acetate is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases,” Cell
159, no. 7 (2014): 1603–1617, 10.1016/j.cell.2014.11.025.
</cite> [<a href="https://doi.org/10.1016/j.cell.2014.11.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4374602/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25525878/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=Acetate%20is%20a%20Bioenergetic%20Substrate%20for%20Human%20Glioblastoma%20and%20Brain%20Metastases&amp;author=T.%20Mashimo&amp;author=K.%20Pichumani&amp;author=V.%20Vemireddy&amp;volume=159&amp;issue=7&amp;publication_year=2014&amp;pages=1603-1617&amp;pmid=25525878&amp;doi=10.1016/j.cell.2014.11.025&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0014">
<span class="label">14.</span><cite>
Michelakis E. D., Sutendra G., Dromparis P., et al., “Metabolic Modulation of Glioblastoma With Dichloroacetate,” Science Translational Medicine
2, no. 31 (2010): 31–34, 10.1126/scitranslmed.3000677.</cite> [<a href="https://doi.org/10.1126/scitranslmed.3000677" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20463368/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science%20Translational%20Medicine&amp;title=Metabolic%20Modulation%20of%20Glioblastoma%20With%20Dichloroacetate&amp;author=E.%20D.%20Michelakis&amp;author=G.%20Sutendra&amp;author=P.%20Dromparis&amp;volume=2&amp;issue=31&amp;publication_year=2010&amp;pages=31-34&amp;pmid=20463368&amp;doi=10.1126/scitranslmed.3000677&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0015">
<span class="label">15.</span><cite>
Flavahan W. A., Wu Q., Hitomi M., et al., “Brain Tumour Initiating Cells Adapt to Restricted Nutrition Through Preferential Glucose Uptake,” Nature Neuroscience
16, no. 10 (2013): 1373–1382, 10.1038/nn.3510.
</cite> [<a href="https://doi.org/10.1038/nn.3510" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3930177/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23995067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Neuroscience&amp;title=Brain%20Tumour%20Initiating%20Cells%20Adapt%20to%20Restricted%20Nutrition%20Through%20Preferential%20Glucose%20Uptake&amp;author=W.%20A.%20Flavahan&amp;author=Q.%20Wu&amp;author=M.%20Hitomi&amp;volume=16&amp;issue=10&amp;publication_year=2013&amp;pages=1373-1382&amp;pmid=23995067&amp;doi=10.1038/nn.3510&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0016">
<span class="label">16.</span><cite>
Wolf A., Agnihotri S., Micallef J., et al., “Hexokinase 2 Is a Key Mediator of Aerobic Glycolysis and Promotes Tumour Growth in Human Glioblastoma Multiforme,” Journal of Experimental Medicine
208, no. 2 (2011): 313–339, 10.1084/jem.20101470.
</cite> [<a href="https://doi.org/10.1084/jem.20101470" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3039857/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21242296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Experimental%20Medicine&amp;title=Hexokinase%202%20Is%20a%20Key%20Mediator%20of%20Aerobic%20Glycolysis%20and%20Promotes%20Tumour%20Growth%20in%20Human%20Glioblastoma%20Multiforme&amp;author=A.%20Wolf&amp;author=S.%20Agnihotri&amp;author=J.%20Micallef&amp;volume=208&amp;issue=2&amp;publication_year=2011&amp;pages=313-339&amp;pmid=21242296&amp;doi=10.1084/jem.20101470&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0017">
<span class="label">17.</span><cite>
Glunde K., Bhujwalla Z. M., and Ronen S. M., “Choline Metabolism in Malignant Transformation,” Nature Reviews. Cancer
11, no. 12 (2011): 835–883, 10.1038/nrc3162.
</cite> [<a href="https://doi.org/10.1038/nrc3162" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4337883/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22089420/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature%20Reviews.%20Cancer&amp;title=Choline%20Metabolism%20in%20Malignant%20Transformation&amp;author=K.%20Glunde&amp;author=Z.%20M.%20Bhujwalla&amp;author=S.%20M.%20Ronen&amp;volume=11&amp;issue=12&amp;publication_year=2011&amp;pages=835-883&amp;pmid=22089420&amp;doi=10.1038/nrc3162&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0018">
<span class="label">18.</span><cite>
Miyake T. and Parsons S. J., “Functional Interactions Between Choline Kinase α, Epidermal Growth Factor Receptor and c‐Src in Breast Cancer Cell Proliferation,” Oncogene
31, no. 11 (2012): 1431–1441, 10.1038/onc.2011.332.
</cite> [<a href="https://doi.org/10.1038/onc.2011.332" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3213328/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21822308/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Functional%20Interactions%20Between%20Choline%20Kinase%20%CE%B1,%20Epidermal%20Growth%20Factor%20Receptor%20and%20c%E2%80%90Src%20in%20Breast%20Cancer%20Cell%20Proliferation&amp;author=T.%20Miyake&amp;author=S.%20J.%20Parsons&amp;volume=31&amp;issue=11&amp;publication_year=2012&amp;pages=1431-1441&amp;pmid=21822308&amp;doi=10.1038/onc.2011.332&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0019">
<span class="label">19.</span><cite>
Corso C. D. and Bindra R. S., “Success and Failures of Combined Modalities in Glioblastoma Multiforme: Old Problems and New Directions,” Seminars in Radiation Oncology
26, no. 4 (2016): 281–298, 10.1016/j.semradonc.2016.06.003.
</cite> [<a href="https://doi.org/10.1016/j.semradonc.2016.06.003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27619250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Seminars%20in%20Radiation%20Oncology&amp;title=Success%20and%20Failures%20of%20Combined%20Modalities%20in%20Glioblastoma%20Multiforme:%20Old%20Problems%20and%20New%20Directions&amp;author=C.%20D.%20Corso&amp;author=R.%20S.%20Bindra&amp;volume=26&amp;issue=4&amp;publication_year=2016&amp;pages=281-298&amp;pmid=27619250&amp;doi=10.1016/j.semradonc.2016.06.003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0020">
<span class="label">20.</span><cite>
Trousil S., Lee P., Pinato D. J., et al., “Alterations of Choline Phospholipid Metabolism in Endometrial Cancer Are Caused by Choline Kinase Alpha Overexpression and a Hyperactivated Deacylation Pathway,” Cancer Research
74, no. 23 (2014): 6867–6877, 10.1158/0008-5472.CAN-13-2409.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-13-2409" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25267063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Alterations%20of%20Choline%20Phospholipid%20Metabolism%20in%20Endometrial%20Cancer%20Are%20Caused%20by%20Choline%20Kinase%20Alpha%20Overexpression%20and%20a%20Hyperactivated%20Deacylation%20Pathway&amp;author=S.%20Trousil&amp;author=P.%20Lee&amp;author=D.%20J.%20Pinato&amp;volume=74&amp;issue=23&amp;publication_year=2014&amp;pages=6867-6877&amp;pmid=25267063&amp;doi=10.1158/0008-5472.CAN-13-2409&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0021">
<span class="label">21.</span><cite>
De Molina A. R., Báñez‐Coronel M., Gutiérrez R., et al., “Choline Kinase Activation Is a Critical Requirement for the Proliferation of Primary Human Mammary Epithelial Cells and Breast Tumour Progression,” Cancer Research
64, no. 18 (2004): 6732–6741, 10.1158/0008-5472.CAN-04-0489.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-04-0489" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15374991/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Choline%20Kinase%20Activation%20Is%20a%20Critical%20Requirement%20for%20the%20Proliferation%20of%20Primary%20Human%20Mammary%20Epithelial%20Cells%20and%20Breast%20Tumour%20Progression&amp;author=A.%20R.%20De%20Molina&amp;author=M.%20B%C3%A1%C3%B1ez%E2%80%90Coronel&amp;author=R.%20Guti%C3%A9rrez&amp;volume=64&amp;issue=18&amp;publication_year=2004&amp;pages=6732-6741&amp;pmid=15374991&amp;doi=10.1158/0008-5472.CAN-04-0489&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0022">
<span class="label">22.</span><cite>
Rodríguez‐González A., De Molina A. R., Fernández F., et al., “Inhibition of Choline Kinase as a Specific Cytotoxic Strategy in Oncogene‐Transformed Cells,” Oncogene
22, no. 55 (2003): 8803–8815, 10.1038/sj.onc.1207062.
</cite> [<a href="https://doi.org/10.1038/sj.onc.1207062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14654777/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=Inhibition%20of%20Choline%20Kinase%20as%20a%20Specific%20Cytotoxic%20Strategy%20in%20Oncogene%E2%80%90Transformed%20Cells&amp;author=A.%20Rodr%C3%ADguez%E2%80%90Gonz%C3%A1lez&amp;author=A.%20R.%20De%20Molina&amp;author=F.%20Fern%C3%A1ndez&amp;volume=22&amp;issue=55&amp;publication_year=2003&amp;pages=8803-8815&amp;pmid=14654777&amp;doi=10.1038/sj.onc.1207062&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0023">
<span class="label">23.</span><cite>
Kumar M., Arlauckas S. P., Saksena S., et al., “Magnetic Resonance Spectroscopy for Detection of Choline Kinase Inhibition in the Treatment of Brain Tumours,” Molecular Cancer Therapeutics
14, no. 4 (2015): 899–908, 10.1158/1535-7163.MCT-14-0775.
</cite> [<a href="https://doi.org/10.1158/1535-7163.MCT-14-0775" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4394035/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25657334/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecular%20Cancer%20Therapeutics&amp;title=Magnetic%20Resonance%20Spectroscopy%20for%20Detection%20of%20Choline%20Kinase%20Inhibition%20in%20the%20Treatment%20of%20Brain%20Tumours&amp;author=M.%20Kumar&amp;author=S.%20P.%20Arlauckas&amp;author=S.%20Saksena&amp;volume=14&amp;issue=4&amp;publication_year=2015&amp;pages=899-908&amp;pmid=25657334&amp;doi=10.1158/1535-7163.MCT-14-0775&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0024">
<span class="label">24.</span><cite>
Bhaduri S., Kelly C. L., Lesbats C., et al., “Metabolic Changes in Glioblastomas in Response to Choline Kinase Inhibition: In Vivo MRS in Rodent Models,” NMR in Biomedicine
36, no. 3 (2023): 4855, 10.1002/nbm.4855.</cite> [<a href="https://doi.org/10.1002/nbm.4855" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10078495/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36269130/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NMR%20in%20Biomedicine&amp;title=Metabolic%20Changes%20in%20Glioblastomas%20in%20Response%20to%20Choline%20Kinase%20Inhibition:%20In%C2%A0Vivo%20MRS%20in%20Rodent%20Models&amp;author=S.%20Bhaduri&amp;author=C.%20L.%20Kelly&amp;author=C.%20Lesbats&amp;volume=36&amp;issue=3&amp;publication_year=2023&amp;pages=4855&amp;pmid=36269130&amp;doi=10.1002/nbm.4855&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0025">
<span class="label">25.</span><cite>
Delgado F., Van Westen A., Nilsson D., et al., “Diagnostic Value of Alternative Techniques to Gadolinium‐Based Contrast Agents in MR Neuroimaging—A Comprehensive Overview,” Insights Into Imaging
10 (2019): 84, 10.1186/s13244-019-0771-1.
</cite> [<a href="https://doi.org/10.1186/s13244-019-0771-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6708018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31444580/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Insights%20Into%20Imaging&amp;title=Diagnostic%20Value%20of%20Alternative%20Techniques%20to%20Gadolinium%E2%80%90Based%20Contrast%20Agents%20in%20MR%20Neuroimaging%E2%80%94A%20Comprehensive%20Overview&amp;author=F.%20Delgado&amp;author=A.%20Van%20Westen&amp;author=D.%20Nilsson&amp;volume=10&amp;publication_year=2019&amp;pages=84&amp;pmid=31444580&amp;doi=10.1186/s13244-019-0771-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0026">
<span class="label">26.</span><cite>
Wen P. Y., Macdonald D. R., Reardon D. A., et al., “Updated Response Assessment Criteria for High‐Grade Gliomas: Response Assessment in Neuro‐Oncology Working Group,” Journal of Clinical Oncology
28, no. 11 (2010): 1963–1972, 10.1200/JCO.2009.26.3541.
</cite> [<a href="https://doi.org/10.1200/JCO.2009.26.3541" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20231676/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Clinical%20Oncology&amp;title=Updated%20Response%20Assessment%20Criteria%20for%20High%E2%80%90Grade%20Gliomas:%20Response%20Assessment%20in%20Neuro%E2%80%90Oncology%20Working%20Group&amp;author=P.%20Y.%20Wen&amp;author=D.%20R.%20Macdonald&amp;author=D.%20A.%20Reardon&amp;volume=28&amp;issue=11&amp;publication_year=2010&amp;pages=1963-1972&amp;pmid=20231676&amp;doi=10.1200/JCO.2009.26.3541&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0027">
<span class="label">27.</span><cite>
Baek H. M., Chen J. H., Nie K., et al., “Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative <sup>1</sup>H MR Spectroscopy,” Radiology
251, no. 3 (2009): 653–662, 10.1148/radiol.2512080553.
</cite> [<a href="https://doi.org/10.1148/radiol.2512080553" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2687529/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19276320/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Predicting%20Pathologic%20Response%20to%20Neoadjuvant%20Chemotherapy%20in%20Breast%20Cancer%20by%20Using%20MR%20Imaging%20and%20Quantitative%201H%20MR%20Spectroscopy&amp;author=H.%20M.%20Baek&amp;author=J.%20H.%20Chen&amp;author=K.%20Nie&amp;volume=251&amp;issue=3&amp;publication_year=2009&amp;pages=653-662&amp;pmid=19276320&amp;doi=10.1148/radiol.2512080553&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0028">
<span class="label">28.</span><cite>
Woodhams R., Kakita S., Hata H., et al., “Identification of Residual Breast Carcinoma Following Neoadjuvant Chemotherapy: Diffusion‐Weighted Imaging—Comparison With Contrast‐Enhanced MR Imaging and Pathologic Findings,” Radiology
254, no. 2 (2010): 357–366, 10.1148/radiol.2542090405.
</cite> [<a href="https://doi.org/10.1148/radiol.2542090405" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20093508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Identification%20of%20Residual%20Breast%20Carcinoma%20Following%20Neoadjuvant%20Chemotherapy:%20Diffusion%E2%80%90Weighted%20Imaging%E2%80%94Comparison%20With%20Contrast%E2%80%90Enhanced%20MR%20Imaging%20and%20Pathologic%20Findings&amp;author=R.%20Woodhams&amp;author=S.%20Kakita&amp;author=H.%20Hata&amp;volume=254&amp;issue=2&amp;publication_year=2010&amp;pages=357-366&amp;pmid=20093508&amp;doi=10.1148/radiol.2542090405&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0029">
<span class="label">29.</span><cite>
Al‐Saffar N. M., Troy H., Ramírez de Molina A., et al., “Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Choline Kinase Inhibitor MN58b in Human Carcinoma Models,” Cancer Research
66, no. 1 (2006): 427–434, 10.1158/0008-5472.CAN-05-1338.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-05-1338" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16397258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Noninvasive%20Magnetic%20Resonance%20Spectroscopic%20Pharmacodynamic%20Markers%20of%20the%20Choline%20Kinase%20Inhibitor%20MN58b%20in%20Human%20Carcinoma%20Models&amp;author=N.%20M.%20Al%E2%80%90Saffar&amp;author=H.%20Troy&amp;author=A.%20Ram%C3%ADrez%20de%20Molina&amp;volume=66&amp;issue=1&amp;publication_year=2006&amp;pages=427-434&amp;pmid=16397258&amp;doi=10.1158/0008-5472.CAN-05-1338&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0030">
<span class="label">30.</span><cite>
Cen L., Carlson B. L., Pokorny J. L., et al., “Efficacy of Protracted Temozolomide Dosing Is Limited in MGMT Unmethylated GBM Xenograft Models,” Neuro‐Oncology
15, no. 6 (2013): 735–746, 10.1093/neuonc/not010.
</cite> [<a href="https://doi.org/10.1093/neuonc/not010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3661094/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23479134/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuro%E2%80%90Oncology&amp;title=Efficacy%20of%20Protracted%20Temozolomide%20Dosing%20Is%20Limited%20in%20MGMT%20Unmethylated%20GBM%20Xenograft%20Models&amp;author=L.%20Cen&amp;author=B.%20L.%20Carlson&amp;author=J.%20L.%20Pokorny&amp;volume=15&amp;issue=6&amp;publication_year=2013&amp;pages=735-746&amp;pmid=23479134&amp;doi=10.1093/neuonc/not010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0031">
<span class="label">31.</span><cite>
Stefan D., Cesare F. D., and Andrasescu A., “Quantitation of Magnetic Resonance Spectroscopy Signals: The JMRUI Software Package,” Measurement Science and Technology
20, no. 10 (2009): 104035, 10.1088/0957-0233/20/10/104035.</cite> [<a href="https://doi.org/10.1088/0957-0233/20/10/104035" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Measurement%20Science%20and%20Technology&amp;title=Quantitation%20of%20Magnetic%20Resonance%20Spectroscopy%20Signals:%20The%20JMRUI%20Software%20Package&amp;author=D.%20Stefan&amp;author=F.%20D.%20Cesare&amp;author=A.%20Andrasescu&amp;volume=20&amp;issue=10&amp;publication_year=2009&amp;pages=104035&amp;doi=10.1088/0957-0233/20/10/104035&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0032">
<span class="label">32.</span><cite>
Vanhamme L., Fierro R. D., Van Huffel S., and De Beer R., “Fast Removal of Residual Water in Proton Spectra,” Journal of Magnetic Resonance
132, no. 2 (1998): 197–203, 10.1016/0022-2364(92)90241-X.
</cite> [<a href="https://doi.org/10.1016/0022-2364(92)90241-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9632545/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Magnetic%20Resonance&amp;title=Fast%20Removal%20of%20Residual%20Water%20in%20Proton%20Spectra&amp;author=L.%20Vanhamme&amp;author=R.%20D.%20Fierro&amp;author=S.%20Van%20Huffel&amp;author=R.%20De%20Beer&amp;volume=132&amp;issue=2&amp;publication_year=1998&amp;pages=197-203&amp;pmid=9632545&amp;doi=10.1016/0022-2364(92)90241-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0033">
<span class="label">33.</span><cite>
Pijnappel W., Vandenboogaart A., De Beer R., and Van Ormondt D., “SVD‐Based Quantification of Magnetic Resonance Signals,” Journal of Magnetic Resonance
97, no. 1 (1992): 122–134, 10.1016/0022-2364(92)90241-X.</cite> [<a href="https://doi.org/10.1016/0022-2364(92)90241-X" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Magnetic%20Resonance&amp;title=SVD%E2%80%90Based%20Quantification%20of%20Magnetic%20Resonance%20Signals&amp;author=W.%20Pijnappel&amp;author=A.%20Vandenboogaart&amp;author=R.%20De%20Beer&amp;author=D.%20Van%20Ormondt&amp;volume=97&amp;issue=1&amp;publication_year=1992&amp;pages=122-134&amp;doi=10.1016/0022-2364(92)90241-X&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0034">
<span class="label">34.</span><cite>
Ratiney H., Coenradi Y., Cavassila S., Ormondt D. V., and Graveron‐Demilly D., “Time‐Domain Quantitation of <sup>1</sup>H Short Echo‐Time Signals: Background Accommodation,” Magnetic Resonance Materials in Physics, Biology and Medicine
16, no. 6 (2004): 284–296.</cite> [<a href="https://doi.org/10.1007/s10334-004-0037-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15168136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Magnetic%20Resonance%20Materials%20in%20Physics,%20Biology%20and%20Medicine&amp;title=Time%E2%80%90Domain%20Quantitation%20of%201H%20Short%20Echo%E2%80%90Time%20Signals:%20Background%20Accommodation&amp;author=H.%20Ratiney&amp;author=Y.%20Coenradi&amp;author=S.%20Cavassila&amp;author=D.%20V.%20Ormondt&amp;author=D.%20Graveron%E2%80%90Demilly&amp;volume=16&amp;issue=6&amp;publication_year=2004&amp;pages=284-296&amp;pmid=15168136&amp;doi=10.1007/s10334-004-0037-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0035">
<span class="label">35.</span><cite>
Ratiney H., Sdika M., Coenradie Y., Cavassila S., Ormondt D. V., and Graveron‐Demilly D., “Time‐Domain Semi‐Parametric Estimation Based on a Metabolite Basis Set,” NMR in Biomedicine
18, no. 1 (2005): 1–13, 10.1006/jmre.1998.1425.
</cite> [<a href="https://doi.org/10.1006/jmre.1998.1425" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15660450/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NMR%20in%20Biomedicine&amp;title=Time%E2%80%90Domain%20Semi%E2%80%90Parametric%20Estimation%20Based%20on%20a%20Metabolite%20Basis%20Set&amp;author=H.%20Ratiney&amp;author=M.%20Sdika&amp;author=Y.%20Coenradie&amp;author=S.%20Cavassila&amp;author=D.%20V.%20Ormondt&amp;volume=18&amp;issue=1&amp;publication_year=2005&amp;pages=1-13&amp;pmid=15660450&amp;doi=10.1006/jmre.1998.1425&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0036">
<span class="label">36.</span><cite>
Gasparovic C., Chen H., and Mullins P. G., “Errors in <sup>1</sup>H‐MRS Estimates of Brain Metabolite Concentrations Caused by Failing to Take Into Account Tissue‐Specific Signal Relaxation,” NMR in Biomedicine
31, no. 6 (2018): 3914, 10.1002/nbm.3914.</cite> [<a href="https://doi.org/10.1002/nbm.3914" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29727496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NMR%20in%20Biomedicine&amp;title=Errors%20in%201H%E2%80%90MRS%20Estimates%20of%20Brain%20Metabolite%20Concentrations%20Caused%20by%20Failing%20to%20Take%20Into%20Account%20Tissue%E2%80%90Specific%20Signal%20Relaxation&amp;author=C.%20Gasparovic&amp;author=H.%20Chen&amp;author=P.%20G.%20Mullins&amp;volume=31&amp;issue=6&amp;publication_year=2018&amp;pages=3914&amp;pmid=29727496&amp;doi=10.1002/nbm.3914&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0037">
<span class="label">37.</span><cite>
De Graaf R. A., Brown P. B., Mcintyre S., Nixon T. W., Behar K. L., and Rothman D. L., “High Magnetic Field Water and Metabolite Proton T1 and T2 Relaxation in Rat Brain In Vivo,” Magnetic Resonance in Medicine
56, no. 2 (2006): 386–394, 10.1002/mrm.20946.
</cite> [<a href="https://doi.org/10.1002/mrm.20946" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16767752/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Magnetic%20Resonance%20in%20Medicine&amp;title=High%20Magnetic%20Field%20Water%20and%20Metabolite%20Proton%20T1%20and%20T2%20Relaxation%20in%20Rat%20Brain%20In%C2%A0Vivo&amp;author=R.%20A.%20De%20Graaf&amp;author=P.%20B.%20Brown&amp;author=S.%20Mcintyre&amp;author=T.%20W.%20Nixon&amp;author=K.%20L.%20Behar&amp;volume=56&amp;issue=2&amp;publication_year=2006&amp;pages=386-394&amp;pmid=16767752&amp;doi=10.1002/mrm.20946&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0038">
<span class="label">38.</span><cite>
Federau C., Maeder P., O'Brien K., Browaeys P., Meuli R., and Hagmann P., “Quantitative Measurement of Brain Perfusion With Intravoxel Incoherent Motion MR Imaging,” Radiology
265, no. 3 (2012): 874–881, 10.1148/radiol.12120584.
</cite> [<a href="https://doi.org/10.1148/radiol.12120584" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23074258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Quantitative%20Measurement%20of%20Brain%20Perfusion%20With%20Intravoxel%20Incoherent%20Motion%20MR%20Imaging&amp;author=C.%20Federau&amp;author=P.%20Maeder&amp;author=K.%20O'Brien&amp;author=P.%20Browaeys&amp;author=R.%20Meuli&amp;volume=265&amp;issue=3&amp;publication_year=2012&amp;pages=874-881&amp;pmid=23074258&amp;doi=10.1148/radiol.12120584&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0039">
<span class="label">39.</span><cite>
Bihan D. L., Breton E., Lallemand D., Aubin M. L., Vignaud J., and Laval‐Jeantet M., “Separation of Diffusion and Perfusion in Intravoxel Incoherent Motion MR Imaging,” Radiology
168, no. 2 (1988): 497–505, 10.1148/radiology.168.2.3393671.
</cite> [<a href="https://doi.org/10.1148/radiology.168.2.3393671" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3393671/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Separation%20of%20Diffusion%20and%20Perfusion%20in%20Intravoxel%20Incoherent%20Motion%20MR%20Imaging&amp;author=D.%20L.%20Bihan&amp;author=E.%20Breton&amp;author=D.%20Lallemand&amp;author=M.%20L.%20Aubin&amp;author=J.%20Vignaud&amp;volume=168&amp;issue=2&amp;publication_year=1988&amp;pages=497-505&amp;pmid=3393671&amp;doi=10.1148/radiology.168.2.3393671&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0040">
<span class="label">40.</span><cite>
Sigmund E. E., Cho G. Y., Kim S., et al., “Intravoxel Incoherent Motion Imaging of Tumor Microenvironment in Locally Advanced Breast Cancer,” Magnetic Resonance in Medicine
65, no. 5 (2011): 1437–1484, 10.1002/mrm.22740.
</cite> [<a href="https://doi.org/10.1002/mrm.22740" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4692245/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21287591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Magnetic%20Resonance%20in%20Medicine&amp;title=Intravoxel%20Incoherent%20Motion%20Imaging%20of%20Tumor%20Microenvironment%20in%20Locally%20Advanced%20Breast%20Cancer&amp;author=E.%20E.%20Sigmund&amp;author=G.%20Y.%20Cho&amp;author=S.%20Kim&amp;volume=65&amp;issue=5&amp;publication_year=2011&amp;pages=1437-1484&amp;pmid=21287591&amp;doi=10.1002/mrm.22740&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0041">
<span class="label">41.</span><cite>
Sumi M., Van Cauteren M., Sumi T., Obara M., Ichikawa Y., and Nakamura T., “Salivary Gland Tumours: Use of Intravoxel Incoherent Motion MR Imaging for Assessment of Diffusion and Perfusion for the Differentiation of Benign From Malignant Tumours,” Radiology
263, no. 3 (2012): 770–777, 10.1148/radiol.12111248.
</cite> [<a href="https://doi.org/10.1148/radiol.12111248" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22447854/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Radiology&amp;title=Salivary%20Gland%20Tumours:%20Use%20of%20Intravoxel%20Incoherent%20Motion%20MR%20Imaging%20for%20Assessment%20of%20Diffusion%20and%20Perfusion%20for%20the%20Differentiation%20of%20Benign%20From%20Malignant%20Tumours&amp;author=M.%20Sumi&amp;author=M.%20Van%20Cauteren&amp;author=T.%20Sumi&amp;author=M.%20Obara&amp;author=Y.%20Ichikawa&amp;volume=263&amp;issue=3&amp;publication_year=2012&amp;pages=770-777&amp;pmid=22447854&amp;doi=10.1148/radiol.12111248&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0042">
<span class="label">42.</span><cite>
Bankhead P., Loughrey M. B., Fernández J. A., et al., “QuPath: Open Source Software for Digital Pathology Image Analysis,” Scientific Reports
7 (2017): 16878, 10.1038/s41598-017-17204-5.
</cite> [<a href="https://doi.org/10.1038/s41598-017-17204-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5715110/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29203879/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Scientific%20Reports&amp;title=QuPath:%20Open%20Source%20Software%20for%20Digital%20Pathology%20Image%20Analysis&amp;author=P.%20Bankhead&amp;author=M.%20B.%20Loughrey&amp;author=J.%20A.%20Fern%C3%A1ndez&amp;volume=7&amp;publication_year=2017&amp;pages=16878&amp;pmid=29203879&amp;doi=10.1038/s41598-017-17204-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0043">
<span class="label">43.</span><cite>
Nwikue G., Olsson‐Brown A., Aboheimed N., et al., “TNF‐<em>α</em> Induced Extracellular Release of Keratinocyte High‐Mobility Group Box 1 in Stevens‐Johnson Syndrome/Toxic Epidermal Necrolysis: Biomarker and Putative Mechanism of Pathogenesis,” Journal of Dermatology
50, no. 9 (2023): 1129–1139, 10.1111/1346-8138.16847.
</cite> [<a href="https://doi.org/10.1111/1346-8138.16847" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10947163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37269158/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Dermatology&amp;title=TNF%E2%80%90%CE%B1%20Induced%20Extracellular%20Release%20of%20Keratinocyte%20High%E2%80%90Mobility%20Group%20Box%C2%A01%20in%20Stevens%E2%80%90Johnson%20Syndrome/Toxic%20Epidermal%20Necrolysis:%20Biomarker%20and%20Putative%20Mechanism%20of%20Pathogenesis&amp;author=G.%20Nwikue&amp;author=A.%20Olsson%E2%80%90Brown&amp;author=N.%20Aboheimed&amp;volume=50&amp;issue=9&amp;publication_year=2023&amp;pages=1129-1139&amp;pmid=37269158&amp;doi=10.1111/1346-8138.16847&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0044">
<span class="label">44.</span><cite>
Sawlani V., Patel M. D., Davies N., et al., “Multiparametric MRI: Practical Approach and Pictorial Review of a Useful Tool in the Evaluation of Brain Tumours and Tumour‐Like Lesions,” Insights Into Imaging
11, no. 1 (2020): 84, 10.1186/s13244-020-00888-1.
</cite> [<a href="https://doi.org/10.1186/s13244-020-00888-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7367972/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32681296/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Insights%20Into%20Imaging&amp;title=Multiparametric%20MRI:%20Practical%20Approach%20and%20Pictorial%20Review%20of%20a%20Useful%20Tool%20in%20the%20Evaluation%20of%20Brain%20Tumours%20and%20Tumour%E2%80%90Like%20Lesions&amp;author=V.%20Sawlani&amp;author=M.%20D.%20Patel&amp;author=N.%20Davies&amp;volume=11&amp;issue=1&amp;publication_year=2020&amp;pages=84&amp;pmid=32681296&amp;doi=10.1186/s13244-020-00888-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0045">
<span class="label">45.</span><cite>
Bhaduri S., Lesbats C., Sharkey J., et al., “Assessing Tumour Haemodynamic Heterogeneity and Response to Choline Kinase Inhibition Using Clustered Dynamic Contrast Enhanced MRI Parameters in Rodent Models of Glioblastoma,” Cancers (Basel)
14 (2022): 1223, 10.3390/cancers14051223.
</cite> [<a href="https://doi.org/10.3390/cancers14051223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8909848/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35267531/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Assessing%20Tumour%20Haemodynamic%20Heterogeneity%20and%20Response%20to%20Choline%20Kinase%20Inhibition%20Using%20Clustered%20Dynamic%20Contrast%20Enhanced%20MRI%20Parameters%20in%20Rodent%20Models%20of%20Glioblastoma&amp;author=S.%20Bhaduri&amp;author=C.%20Lesbats&amp;author=J.%20Sharkey&amp;volume=14&amp;publication_year=2022&amp;pages=1223&amp;pmid=35267531&amp;doi=10.3390/cancers14051223&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0046">
<span class="label">46.</span><cite>
Hattingen E., Raab P., Franz K., Zanella F. E., Lanfermann H., and Pilatus U., “Myo‐Inositol: A Marker of Reactive Astrogliosis in Glial Tumours?,” NMR in Biomedicine
21 (2008): 233–274, 10.1002/nbm.1186.
</cite> [<a href="https://doi.org/10.1002/nbm.1186" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17562554/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NMR%20in%20Biomedicine&amp;title=Myo%E2%80%90Inositol:%20A%20Marker%20of%20Reactive%20Astrogliosis%20in%20Glial%20Tumours?&amp;author=E.%20Hattingen&amp;author=P.%20Raab&amp;author=K.%20Franz&amp;author=F.%20E.%20Zanella&amp;author=H.%20Lanfermann&amp;volume=21&amp;publication_year=2008&amp;pages=233-274&amp;pmid=17562554&amp;doi=10.1002/nbm.1186&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0047">
<span class="label">47.</span><cite>
Toussaint M., Pinel S., Auger F., et al., “Proton MR Spectroscopy and Diffusion MR Imaging Monitoring to Predict Tumor Response to Interstitial Photodynamic Therapy for Glioblastoma,” Theranostics
7, no. 2 (2017): 436–451, 10.7150/thno.17218.
</cite> [<a href="https://doi.org/10.7150/thno.17218" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5327359/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28255341/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Theranostics&amp;title=Proton%20MR%20Spectroscopy%20and%20Diffusion%20MR%20Imaging%20Monitoring%20to%20Predict%20Tumor%20Response%20to%20Interstitial%20Photodynamic%20Therapy%20for%20Glioblastoma&amp;author=M.%20Toussaint&amp;author=S.%20Pinel&amp;author=F.%20Auger&amp;volume=7&amp;issue=2&amp;publication_year=2017&amp;pages=436-451&amp;pmid=28255341&amp;doi=10.7150/thno.17218&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0048">
<span class="label">48.</span><cite>
He T., Doblas S., Saunders D., et al., “Effects of PBN and OKN007 in Rodent Glioma Models Assessed by <sup>1</sup>H MR Spectroscopy,” Free Radical Biology and Medicine
51 (2011): 490–502, 10.1016/j.freeradbiomed.2011.04.037.
</cite> [<a href="https://doi.org/10.1016/j.freeradbiomed.2011.04.037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21600283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Free%20Radical%20Biology%20and%20Medicine&amp;title=Effects%20of%20PBN%20and%20OKN007%20in%20Rodent%20Glioma%20Models%20Assessed%20by%201H%20MR%20Spectroscopy&amp;author=T.%20He&amp;author=S.%20Doblas&amp;author=D.%20Saunders&amp;volume=51&amp;publication_year=2011&amp;pages=490-502&amp;pmid=21600283&amp;doi=10.1016/j.freeradbiomed.2011.04.037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0049">
<span class="label">49.</span><cite>
Delgado‐Goñi T., Ortega‐Martorell S., Ciezka M., et al., “MRSI‐Based Molecular Imaging of Therapy Response to Temozolomide in Preclinical Glioblastoma Using Source Analysis,” NMR in Biomedicine
29, no. 6 (2016): 732–743, 10.1002/nbm.3521.
</cite> [<a href="https://doi.org/10.1002/nbm.3521" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27061401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=NMR%20in%20Biomedicine&amp;title=MRSI%E2%80%90Based%20Molecular%20Imaging%20of%20Therapy%20Response%20to%20Temozolomide%20in%20Preclinical%20Glioblastoma%20Using%20Source%20Analysis&amp;author=T.%20Delgado%E2%80%90Go%C3%B1i&amp;author=S.%20Ortega%E2%80%90Martorell&amp;author=M.%20Ciezka&amp;volume=29&amp;issue=6&amp;publication_year=2016&amp;pages=732-743&amp;pmid=27061401&amp;doi=10.1002/nbm.3521&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0050">
<span class="label">50.</span><cite>
Subramani E., Radoul M., Najac C., et al., “Glutamate Is a Noninvasive Metabolic Biomarker of IDH1‐Mutant Glioma Response to Temozolomide Treatment,” Cancer Research
80, no. 22 (2020): 5098–5108, 10.1158/0008-5472.CAN-20-1314.
</cite> [<a href="https://doi.org/10.1158/0008-5472.CAN-20-1314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7669718/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32958546/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Research&amp;title=Glutamate%20Is%20a%20Noninvasive%20Metabolic%20Biomarker%20of%20IDH1%E2%80%90Mutant%20Glioma%20Response%20to%20Temozolomide%20Treatment&amp;author=E.%20Subramani&amp;author=M.%20Radoul&amp;author=C.%20Najac&amp;volume=80&amp;issue=22&amp;publication_year=2020&amp;pages=5098-5108&amp;pmid=32958546&amp;doi=10.1158/0008-5472.CAN-20-1314&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0051">
<span class="label">51.</span><cite>
Radoul M., Hong D., Gillespie A. M., et al., “Early Noninvasive Metabolic Biomarkers of Mutant IDH Inhibition in Glioma,” Metabolites
11 (2021): 109, 10.3390/metabo11020109.
</cite> [<a href="https://doi.org/10.3390/metabo11020109" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7917625/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33668509/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metabolites&amp;title=Early%20Noninvasive%20Metabolic%20Biomarkers%20of%20Mutant%20IDH%20Inhibition%20in%20Glioma&amp;author=M.%20Radoul&amp;author=D.%20Hong&amp;author=A.%20M.%20Gillespie&amp;volume=11&amp;publication_year=2021&amp;pages=109&amp;pmid=33668509&amp;doi=10.3390/metabo11020109&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0052">
<span class="label">52.</span><cite>
Mahmood F., Johannesen H. H., Geertsen P., and Hansen R. H., “Repeated Diffusion MRI Reveals Earliest Time Point for Stratification of Radiotherapy Response in Brain Metastases,” Physics in Medicine and Biology
62, no. 8 (2017): 2990–3002, 10.1088/1361-6560/aa5249.
</cite> [<a href="https://doi.org/10.1088/1361-6560/aa5249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28306548/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Physics%20in%20Medicine%20and%20Biology&amp;title=Repeated%20Diffusion%20MRI%20Reveals%20Earliest%20Time%20Point%20for%20Stratification%20of%20Radiotherapy%20Response%20in%20Brain%20Metastases&amp;author=F.%20Mahmood&amp;author=H.%20H.%20Johannesen&amp;author=P.%20Geertsen&amp;author=R.%20H.%20Hansen&amp;volume=62&amp;issue=8&amp;publication_year=2017&amp;pages=2990-3002&amp;pmid=28306548&amp;doi=10.1088/1361-6560/aa5249&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0053">
<span class="label">53.</span><cite>
Paudyal R., Oh J. H., Riaz N., et al., “Intravoxel Incoherent Motion Diffusion‐Weighted MRI During Chemoradiation Therapy to Characterize and Monitor Treatment Response in Human Papillomavirus Head and Neck Squamous Cell Carcinoma,” Journal of Magnetic Resonance Imaging
45, no. 4 (2017): 1013–1023, 10.1002/jmri.25523.
</cite> [<a href="https://doi.org/10.1002/jmri.25523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5363344/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27862553/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Magnetic%20Resonance%20Imaging&amp;title=Intravoxel%20Incoherent%20Motion%20Diffusion%E2%80%90Weighted%20MRI%20During%20Chemoradiation%20Therapy%20to%20Characterize%20and%20Monitor%20Treatment%20Response%20in%20Human%20Papillomavirus%20Head%20and%20Neck%20Squamous%20Cell%20Carcinoma&amp;author=R.%20Paudyal&amp;author=J.%20H.%20Oh&amp;author=N.%20Riaz&amp;volume=45&amp;issue=4&amp;publication_year=2017&amp;pages=1013-1023&amp;pmid=27862553&amp;doi=10.1002/jmri.25523&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0054">
<span class="label">54.</span><cite>
Zhou Y., Zheng J., Yang C., et al., “Application of Intravoxel Incoherent Motion Diffusion‐Weighted Imaging in Hepatocellular Carcinoma,” World Journal of Gastroenterology
28, no. 27 (2022): 3334–3345, 10.3748/wjg.v28.i27.3334.
</cite> [<a href="https://doi.org/10.3748/wjg.v28.i27.3334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9346463/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36158259/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=World%20Journal%20of%20Gastroenterology&amp;title=Application%20of%20Intravoxel%20Incoherent%20Motion%20Diffusion%E2%80%90Weighted%20Imaging%20in%20Hepatocellular%20Carcinoma&amp;author=Y.%20Zhou&amp;author=J.%20Zheng&amp;author=C.%20Yang&amp;volume=28&amp;issue=27&amp;publication_year=2022&amp;pages=3334-3345&amp;pmid=36158259&amp;doi=10.3748/wjg.v28.i27.3334&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0055">
<span class="label">55.</span><cite>
Liang J., Li Z., Li J., et al., “Application of IVIM‐DWI in Detecting the Tumour Vasculogenic Mimicry Under Antiangiogenesis Combined With Oxaliplatin Treatment,” Frontiers in Oncology
10 (2020): 1376, 10.3389/fonc.2020.01376.
</cite> [<a href="https://doi.org/10.3389/fonc.2020.01376" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7461873/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32974136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Oncology&amp;title=Application%20of%20IVIM%E2%80%90DWI%20in%20Detecting%20the%20Tumour%20Vasculogenic%20Mimicry%20Under%20Antiangiogenesis%20Combined%20With%20Oxaliplatin%20Treatment&amp;author=J.%20Liang&amp;author=Z.%20Li&amp;author=J.%20Li&amp;volume=10&amp;publication_year=2020&amp;pages=1376&amp;pmid=32974136&amp;doi=10.3389/fonc.2020.01376&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0056">
<span class="label">56.</span><cite>
Strobel H., Baisch T., Fitzel R., et al., “Temozolomide and Other Alkylating Agents in Glioblastoma Therapy,” Biomedicine
7, no. 3 (2019): 69, 10.3390/biomedicines7030069.</cite> [<a href="https://doi.org/10.3390/biomedicines7030069" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6783999/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31505812/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine&amp;title=Temozolomide%20and%20Other%20Alkylating%20Agents%20in%20Glioblastoma%20Therapy&amp;author=H.%20Strobel&amp;author=T.%20Baisch&amp;author=R.%20Fitzel&amp;volume=7&amp;issue=3&amp;publication_year=2019&amp;pages=69&amp;pmid=31505812&amp;doi=10.3390/biomedicines7030069&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0057">
<span class="label">57.</span><cite>
Kelly C. L., Wydrzynska M., Phelan M. M., et al., “Hypoxia Dependent Inhibition of Glioblastoma Cell Proliferation, Invasion, and Metabolism by the Choline‐Kinase Inhibitor JAS239,” Metabolites
15, no. 2 (2025): 76, 10.3390/metabo15020076.
</cite> [<a href="https://doi.org/10.3390/metabo15020076" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11857610/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39997701/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Metabolites&amp;title=Hypoxia%20Dependent%20Inhibition%20of%20Glioblastoma%20Cell%20Proliferation,%20Invasion,%20and%20Metabolism%20by%20the%20Choline%E2%80%90Kinase%20Inhibitor%20JAS239&amp;author=C.%20L.%20Kelly&amp;author=M.%20Wydrzynska&amp;author=M.%20M.%20Phelan&amp;volume=15&amp;issue=2&amp;publication_year=2025&amp;pages=76&amp;pmid=39997701&amp;doi=10.3390/metabo15020076&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="nbm70113-bib-0058">
<span class="label">58.</span><cite>
Nath K., Nelson D. S., Roman J., et al., “Effect of Lonidamine on Systemic Therapy of DB‐1 Human Melanoma Xenografts With Temozolomide,” Anticancer Research
37, no. 7 (2017): 3413–3421, 10.21873/anticanres.117.
</cite> [<a href="https://doi.org/10.21873/anticanres.117" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8757536/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28668829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer%20Research&amp;title=Effect%20of%20Lonidamine%20on%20Systemic%20Therapy%20of%20DB%E2%80%901%20Human%20Melanoma%20Xenografts%20With%20Temozolomide&amp;author=K.%20Nath&amp;author=D.%20S.%20Nelson&amp;author=J.%20Roman&amp;volume=37&amp;issue=7&amp;publication_year=2017&amp;pages=3413-3421&amp;pmid=28668829&amp;doi=10.21873/anticanres.117&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><p>
<strong>Data S1:</strong> Supporting information.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12319478/bin/NBM-38-e70113-s001.docx" data-ga-action="click_feat_suppl" class="usa-link">NBM-38-e70113-s001.docx</a><sup> (1.1MB, docx) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="caption p"><p>
<strong>Figure S1:</strong> A representative <sup>1</sup>H MRS spectrum illustrating the fitting performance from a 9L tumor‐bearing rat (original spectra in blue, fitted spectra in red, and residual in black). This figure is from on our previously published work by Bhaduri et al. [25], which used the same acquisition and quantification pipeline for GL261 glioma models reported in this paper.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12319478/bin/NBM-38-e70113-s004.tiff" data-ga-action="click_feat_suppl" class="usa-link">NBM-38-e70113-s004.tiff</a><sup> (116.6KB, tiff) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material3_reqid_"><div class="caption p"><p>
<strong>Figure S2:</strong> Examples of the digital analysis workflow for caspase‐3: (A) Low power magnification of tumor (*) surrounded by normal parenchyma (**) identified as region of interest (ROI—yellow line). Scalebar: 800 μm. (B) High power magnification of the segmentation mask for caspase‐3 negative (blue) and positive (red) cells. Scalebar: 50 μm.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12319478/bin/NBM-38-e70113-s003.tiff" data-ga-action="click_feat_suppl" class="usa-link">NBM-38-e70113-s003.tiff</a><sup> (984.6KB, tiff) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material4_reqid_"><div class="caption p"><p>
<strong>Table S1:</strong> Summary of non‐significant parameters at baseline, Day 3, and Day 6. Data are presented as the mean ± standard deviation. The <em>p</em>‐value for the comparison with the control group is presented in brackets.</p></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12319478/bin/NBM-38-e70113-s002.docx" data-ga-action="click_feat_suppl" class="usa-link">NBM-38-e70113-s002.docx</a><sup> (16.4KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Nmr in Biomedicine are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1002/nbm.70113"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/NBM-38-e70113.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (5.5 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12319478/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12319478/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12319478%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12319478/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12319478/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12319478/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40755153/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12319478/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40755153/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12319478/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12319478/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="iMdTqkBRKNCihhrof38xUK4NrJ0IA10EM4O0SCDwnb75JNEzyFanEOzgQtsStS2j">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-d9849939.js"></script>
    
    

    </body>
</html>
